Skip to main content
PLOS One logoLink to PLOS One
. 2026 Jan 2;21(1):e0339054. doi: 10.1371/journal.pone.0339054

Epidemiological analysis reveals coral species affected by stony coral tissue loss disease present a similar epizootic progression despite differences in susceptibility and population impact

Edgar Omar Guzmán-Urieta 1,2,*, Eric Jordán-Dahlgren 3, Lorenzo Alvarez-Filip 2
Editor: Parviz Tavakoli-Kolour4
PMCID: PMC12758708  PMID: 41481580

Abstract

Stony coral tissue loss disease (SCTLD) is one of the most aggressive coral syndromes recorded, affecting over 30 scleractinian species and causing high mortality rates. Despite its impact, most available information is derived from assessments that estimate prevalence at a single point in time, rather than examining its temporal dynamics. This study analyzed the susceptibility of 16 coral species to SCTLD and tracked the 2018–2019 outbreak on a fringing reef in the Mexican Caribbean using epidemiological methods commonly employed in human epidemics but rarely in coral epizootics. Between June 2018 and July 2019, we monitored 990 coral colonies. For each affected colony, we estimated the progression of tissue death over time, allowing us to identify the days of lesion onset and total tissue mortality. To assess vulnerability and provide a detailed prognosis of outbreak progression, magnitude, and severity during the epizootic we employed epidemic curves, Kaplan-Meier risk and survival functions, and measures of period prevalence and mortality. Epidemiological parameters from these analyses were integrated into a multi-dimensional framework for a comprehensive assessment of coral susceptibility. Our findings revealed that species-specific susceptibility was associated with the risk, magnitude, and severity of the epizootic but not with its progression. Temporal analyses revealed community-level patterns, including secondary outbreak waves following increases in mortality. This suggests a potential feedback mechanism, where mortality may contribute to secondary transmission events, a phenomenon not previously described in the study of coral epizootics. As a contribution to the characterization of coral susceptibility to SCTLD, we outline a four-level framework based on diverse epidemiological indicators, beyond prevalence. This approach revealed a higher-than-expected susceptibility in Siderastrea siderea, Agaricia agaricites and Agaricia tenuifolia, compared to previous studies. This study underscores the importance of epidemiological approaches in investigating coral epizootics. By challenging traditional reliance on prevalence measurements, our findings offer a novel perspective on coral disease dynamics.

Introduction

Coral reefs are one of the most biodiverse ecosystems in the world [1]; their complex structure and energetic dynamism allow the development of hundreds of species and provide goods and services for coastal human communities [2]. Paradoxically, the entire system depends on the tiny and highly vulnerable polyps of hermatypic corals. These organisms have narrow environmental requirements, and repeated or prolonged deviations from these conditions can lead to physiological dysfunctions and increase their susceptibility to pathogens [3]. Therefore, it is not surprising that the occurrence of coral disease and its severity has rapidly increased during the last decades following an increase in environmental pressures in the form of water pollution, eutrophication and ocean warming [4,5].

Among coral disease outbreaks, the most devastating for the Caribbean reefs in the past decade has been caused by a white syndrome known as stony coral tissue loss disease (SCTLD) [68]. SCTLD is a breakpoint for the ecological integrity of Caribbean reefs, as this disease drastically changed coral cover and coral composition and impacted key processes such as habitat provisioning and production of calcium-carbonated structures [912]. Despite the severity of this coral syndrome, the etiology of SCTLD remains unknown. Multiple bacteria and some viruses have been linked to lesions (e.g., [1318]) yet their role in the development of the disease is unclear, whether as primary or secondary pathogens [1921]. At the regional scale, the spread corresponds to a contagious pattern [22], but at the local level the pattern is inconsistent. On the one hand, Williams et al. [23] and Dahlgren et al. [24] observed spatial dependence among SCTLD colonies and a higher risk of lesions occurrence in colonies near diseased neighbors, on reefs in the Lower Florida Keys and Bahamas, respectively. On the other hand, Sharp et al. [25] and Guzmán-Urieta & Jordán-Dahlgren [26] observed that SCTLD spatial incidence was independent of nearest neighbor condition. This suggests that at a small scale, the spread pattern could be influenced by environmental characteristics, host conditions, and species-specific susceptibility [23,26,27].

SCTLD has severely impacted populations of over 30 coral species [6]. The most highly affected are now at a clear risk of extinction across their distribution ranges [28]. Other susceptible species, such as brain corals, which experienced comparatively lower declines (30–70%) may have compromised their viable population sizes [26,29]. Among the coral species affected by SCTLD, there is high variability of epidemiological indicators such as the time to disease onset, lesion progression rate, and prevalence that was interpreted as species-specific susceptibility [7,8,27,2933]. Yet, prevalence, i.e., the proportion of diseased individuals in a specific place and time [34], is the primary epidemiological descriptor used to quantify the degree of susceptibility of different species (S1 Table) and to compare the disease magnitude and severity between sites. For example, in the first published SCTLD case definition [30], species susceptibility was categorized by its prevalence, tissue mortality rates, and sequence of lesion appearance; likewise, many other studies have assigned level of susceptibility, described regional trends and compared between localities or environments using prevalence (e.g., [32,35]).

However, prevalence depends on the moment of measurement [36], and it does not allow for the distinction of epizootic progression, offering a limited perspective. For example, suppose prevalence is measured at different times within the same population impacted by an epizootic event (Fig 1A). In that case, different prevalence values can be obtained depending on the measurement time, likely obscuring the understanding of the disease outbreak. A relevant example is the study by Dahlgren et al. [24], which documented spatial and temporal variation in SCTLD prevalence across coral species over a 6–10 month period in Bahamian reefs. This underscores the challenge of comparing species susceptibility based solely on prevalence, as each species may exhibit different prevalence levels depending on the stage of the outbreak (Fig 1B). In contrast, tracking the event over time allows for the identification of epidemiologically and ecologically meaningful patterns in species susceptibility.

Fig 1. Schematic of the SCTLD prevalence changes through time.

Fig 1

A) Differentiating among the three theoretical responses of coral species susceptibility to SCTLD: high (red), intermediate (yellow) and low (blue). Black arrows mark the epizootic start of each species based on the observations of FDEP [30]. From this differential epizootic start a prevalence peak is inferred at different times. Dashed lines show three hypothetical sampling periods (S1, S2 & S3) that produce the different prevalence estimates shown in B). B) Bars indicate that species prevalence will vary depending on the sampling time.

A classic perspective for analyzing the progression of an epidemic is the use of epidemic curves (epi-curves). Since its implementation by John Graunt in the middle of the 17th century with the Plague [37], epi-curves have been commonly used to analyze infectious and non-infectious disease outbreaks in humans and animals (i.e., [38,39]). These curves show the onset of cases (incidence) of an outbreak. They help to determine the progression, development and magnitude of an epidemic or epizootic, distinguish epizootic from enzootic phases, and enabling comparisons with potentially correlated factors. The shape of an epi-curve can inform about mode of spread, which could be from a common source (with punctual, continuous or intermittent discharges) or a propagated outbreak due to transmission from one individual to another. Also, if epi-curves are normalized as incidence rate curves, they can be used to compare the severity of the epizootic magnitude between sites and/or species [34,4043]. Characteristics of epi-curves such as peak timing, peak height, curve duration, and curve shape, are all relevant measures of epizootic severity and are helpful to predict future events [41,42]. And, assuming exposure to an agent at the same time, comparison of epi-curves can help determine the degree of susceptibility between sites or/and species.

Despite the great level of detail they provide, epi-curves have not been used much on coral epizootics. We systematically searched for studies on coral epizootics in Web of Science [44] (S2 Table) and found that, among 439 studies conducted between 1995 and 2025, only 3.4% used or implemented approximations of epi-curves in their analysis, with only two studies focusing on SCTLD. Other 15.9% used prevalence vs. time curves, which show changes in the diseased population and can differentiate between enzootic and epizootic phases [45], yet do not portray accurately the epizootic progression as the curve is shaped by new cases, deaths, recoveries and not found individuals (censoring). And the 80.7% remaining only uses the words prevalence/incidence without epizootic analysis or use prevalence measures to compare affectation between sites or species. The implementation of epi-curves in SCTLD analysis would therefore allow for further understanding of the epizootic progression and an opportunity to improve the current epizootic surveillance protocols, allowing for better predictive capacity.

In this study, we aimed to investigate the progression, magnitude and severity of an SCLTD epizootic by tracking the condition of nearly one thousand colonies from 16 coral species for thirteen months in a shallow fringing reef. We reconstructed individual tissue loss trajectories for each affected colony, to estimate the timing of disease onset, recovery, or death during the epizootic. This allowed us to implement a framework based on epi-curves and Kaplan-Meier risk and survival analyses to assess the vulnerability of the coral community to SCTLD, and to provide a detailed prognosis of the outbreak’s progression, magnitude and severity. Furthermore, by integrating the assessed epidemiological parameters into a multi-dimensional space, we outline a four-level framework that contributes to the characterization of species susceptibility to SCTLD. We believe our findings provide a novel perspective on understanding this highly aggressive disease, contributing to a more precise depiction of outbreak progression patterns, particularly in regions where only prevalence information (e.g., Fig 1) has been produced and, therefore likely aiding to understand the timing and implications of the outbreak more precisely.

Methods

Data collection

In order to describe the progression, magnitude and severity of the SCTLD epizootic, we conducted approximately biweekly evaluations of the coral communities at two sites afflicted by the SCTLD and located 1,100 m apart in the Puerto Morelos reef, Mexican Caribbean. One site, Bocana (20°52’29”N and 86°51’06”W) is located at the lagoon-ward end of an active channel. The other site, Picudas, (20°53’02”N and 86°50’54”W) experiences a more pronounced wave regime due to a lower reef crest and nearby a wide reef opening [26]. Both sites are 5m deep. Surveys started near the onset of the SCTLD epizootic and continued for one year (from June 2018 to July 2019), completing a total of 31 surveys across both sites.

At Bocana, four sampling points were established: B1 (453 m2), B2 (19.5 m2), B3 (140 m2), and B4 (60 m2). At Picudas, three points were defined: P1 (435 m2), P2 (12 m2) and P3 (9 m2). These polygons were delimited by reef topography and visibility constraints, but remained fixed throughout the study. Despite differences in size, consistent effort was applied within each polygon to document all visible coral colonies across species during each visit through photographic surveys.

Initially, monitoring was focused on spatial disease patterns in Pseudodiploria strigosa, as part of a previous study on SCTLD dynamics [26]. However, during those surveys, photographic records were systematically taken of all visible coral colonies within the same sampling areas, regardless of species. Each colony was photographed individually during every monitoring event, with multiple angles captured depending on its size and structural complexity. These images allowed us to track colonies over time and retrospectively assess their health status (healthy, diseased, or dead), visually estimate the percentage of dead tissue caused by SCTLD or previous mortality, and classify lesion progression type (acute, subacute, or chronic, sensu Work & Aeby [46]). Additionally, the maximum diameter of each colony at the onset of the study was measured using ImageJ (1.52a), based on scale markers included in the photographs.

As a result of these surveys, a total of 1,007 colonies of 26 coral species were recorded. Among these, 990 colonies belonged to 16 species that exhibited SCTLD signs in at least one individual during the study period (n = 422). Further analyses were conducted on these 16 species. Given that our previous approximation did not detect spatial differences in SCTLD distribution between sites [26], cases from both sites were merged to increase the sample size. This broader approach is further supported by Sharp et al. [25], who found that SCTLD transmission may not be associated with the density of susceptible individuals, reinforcing the rationale for merging data from both sites to improve statistical power.

Individual disease status reconstruction

To construct epidemic curves, determine daily status of prevalence and mortality, and to perform Kaplan-Meier risk and survival analyses, we needed to estimate when each affected colony began showing disease signs and when it either died or recovered. To achieve this, we reconstructed individual tissue loss trajectories using the percentage of dead tissue recorded for each affected colony (n = 422) at every monitoring event. The method used to estimate these trajectories depended on the number of available records per individual, resulting in four distinct methodological approaches: I) for individuals with more than two records; II) for individuals with exactly two records; and III) and IV) for individuals with only one recorded percentage of tissue loss. The details of each approach are described below.

  • I

    For afflicted colonies that survived at least three observation periods (n = 123), we fitted individual Generalized Additive Mixed Models (GAMMs) for each colony, incorporating an autocorrelation structure (corARMA, corAR, or corCAR) selected based on the diagnostic residuals. To ensure model robustness, we assessed residual normality (Anderson-Darling test and histogram), homoscedasticity (White test), and the absence of autocorrelation (Durbin-Watson test). The results are provided in S3 Table. Given the limited number of observations, residuals were preprocessed using an iterative resampling approach (wild bootstrap). Finally, to determine the time of disease onset and complete tissue death, we interpolated the time points at which dead tissue reached 0.01% and 100%, respectively. This methodological framework accounts for the potential dependence between observations, as tissue loss percentages represent repeated measures within the same individual.

  • II

    For diseased individuals recorded at only two time points (n = 81), we applied a deterministic method based on the linear equation:

y=m·x+b (1)

where (y) represents the percentage of tissue loss, (x) denotes time, (m) is the slope, and (b) is the intercept. The slope and intercept were calculated as follows:

m=y2y1x2x1 (2)
b=y1(m·x1) (3)

The times corresponding to disease onset and complete tissue mortality were determined by solving for (x) in the linear equation, substituting the intercept and slope, and using (y) values of 0.01% for onset and 100% for mortality:

x=ybm (4)

For colonies with only one recorded observation of tissue loss, we acknowledge that direct estimation of lesion progression is not possible. To avoid excluding these cases, we implemented two approaches based on biologically informed assumptions and empirical reference data. These methods aim to reconstruct plausible trajectories while accounting for uncertainty, as detailed in points III and IV.

  • III

    The third approach was implemented for diseased colonies with only one recorded instance of tissue loss. These cases occurred either because the colonies were too small to relocate or because they died and were likely rapidly overgrown by algae, resulting in their capture as diseased during only one survey (n = 130). To address this limitation, we assumed that these individuals followed a similar trajectory to others of the same species, size category (small: < 33 cm; medium: > 33–66 cm; large: > 66 to <100 cm; and extra-large: > 100 cm), and lesion progression type. Based on this assumption, we first calculated individual tissue loss trajectories from colonies with sufficient temporal data, grouped by species, size category, and lesion progression type. From these trajectories, we derived an average daily tissue loss rate, which was then used to interpolate the percentage of tissue loss for colonies with only one recorded observation. This allowed us to estimate the full progression trajectory, including onset and extent of tissue loss, for single-observation cases. This procedure is illustrated in S1 Fig. A 95% confidence interval for each extrapolated trajectory was computed using the bootstrap percentile method and is provided for reference (S4 Table).

  • IV. For diseased colonies with only one tissue mortality record that could not be matched to any of the above categories of species, size, and lesion progression (n = 88), we estimated their individual tissue loss trajectories based on the colonization stage of the exposed skeleton. These stages (recent mortality, algal/microbial film, turf algae, and macroalgae) follow a consistent post-mortality succession (S2 Fig). Each stage was associated with an average transition time, calculated from a reference subsample of 157 colonies (S5 Table). Using this information, we inferred when each skeletal region was covered by living tissue. Colonies displaying multiple colonization stages provided several time points along the lesion progression. Depending on the number of inferred points, we then applied either a GAMM or a linear interpolation method (as in cases I and II, respectively) to reconstruct the full trajectory of tissue loss, from lesion onset to complete mortality.

All analyses were conducted in R using the following packages: mgcv v.1.9–3 [47] for GAMM modeling, boot v.1.3–31 [48] for bootstrap resampling, car v.3.1–3 [49] for White’s test of heteroscedasticity, nortest v.1.0–4 [50] for the Anderson-Darling normality test, and lmtest v.0.9–40 [51] for the Durbin-Watson autocorrelation test.

SCTLD epizootic progression and magnitude

Here two common epidemiological methods were applied to assess the vulnerability of coral community to SCTLD, and to provide a detailed prognosis of the epizootic’s progression and magnitude: epidemic curves and Kaplan-Meier survival and risk analyses. These curves were computed both by individual species and by species grouped accordingly to their expected susceptibility (high, intermediate and low; sensu FDEP [30] and Papke et al., [33]). This analysis evaluates whether species grouped by expected susceptibility-based groups exhibit consistent differences not only in period prevalence and cumulative mortality, but also in other epidemiological indicators throughout the course of the epizootic. The list of species by group is provided in Table 1.

Table 1. Epizootic parameters used to assess species susceptibility to SCTLD.

Expected susceptibility Species N Time at first (days) Time at 5% prevalence (days) Epizootic peak time (days) Outbreak length (days) Population survival probability Diseased survival probability Risk at end Period prevalence (%) Cumulative mortality (%) Incidence rate at peak (%)
High Colpophyllia natans (CNAT) 17 52 52 92 181 0.07 0 0.92 100 100 27.3
Dichocoenia stokesii (DSTO) 6 23 23 71 51 0 0 1 100 100 66.7
Eusmilia fastigiata (EFAS) 1 24 24 24 1 1 1 1 100 0 100
Meandrina jacksoni (MJAC) 2 27 27 29 10 0 0 1 100 100 50
Pseudodiploria clivosa (PCLI) 5 1 1 1 114 0.6 0 0.4 60 60 20
Pseudodiploria strigosa (PSTR) 198 3 39 99 390 0.05 0.006 0.87 95.5 94.9 7.6
Intermediate Montastraea cavernosa (MCAV) 56 56 78 169 228 0.34 0 0.56 66.1 66.1 13.3
Orbicella annularis (OANN) 12 87 87 92 50 0.62 0.42 0.63 66.6 40 9.1
Orbicella faveolata (OFAV) 36 55 71 113 276 0.62 0.26 0.44 50 36.1 9.4
Stephanocoenia intersepta (SINT) 18 117 117 120 172 0.64 0 0.20 27.8 27.8 5.6
Siderastrea siderea (SSID) 211 21 69 99 264 0.13 0.06 0.76 89.6 83.9 12.8
Low Agaricia agaricites (AAGA) 255 12 109 113 322 0.70 0.08 0.21 27.5 25.1 2.1
Agaricia tenuifolia (ATEN) 46 88 115 92 285 0.52 0.11 0.37 43.5 39.1 2.6
Isophyllia sinuosa (ISIN) 8 184 184 190 1 0.87 0 0.12 12.5 12.5 12.5
Porites astreoides (PAST) 101 44 104 288 248 0.76 0.23 0.15 21.8 16.8 4.2
Porites porites (PPOR) 18 285 285 288 1 0.83 0 0.07 11.1 11.1 7.1

Species are grouped according to their expected susceptibility sensu [30] and [33]. AGRRA codes in brackets.

Epizootic curves

Typically, the progression of an epizootic is characterized by successive stages: onset, increase in cases, peak, decline, and finally, stabilization or elimination of incidence [41]. This progression is depicted in the curve of incidence over time, known as an epizootic curve (epi-curve). Epi-curves by species and by susceptibility group were plotted using the Incidence R package [52]. These curves are generated using a list of the afflicted colonies by species and their corresponding date of signs onset. To highlight patterns in case emergence, epi-curves were constructed as weekly histograms. To estimate 95% confidence intervals (CI) for epizootic peak dates for each group, the original dates by species or groups were resampled with using the bootstrap method with replacement (1000 iterations; alpha = 0.05). The first highest mode in the bootstrap data was selected as the peak date.

After observing secondary waves in the combined epi-curve, we hypothesized that these might be linked to the dispersal of the causative agent from sloughed tissue of dying colonies, which are potentially laden with microorganisms that could contribute to the feedback of the epizootic [30,33,53]. To explore whether mortality could help explain the observed incidence patterns, we visually compared the temporal alignment of daily incidence and mortality curves by overlaying their kernel density distributions. Additionally, to rule out the possibility that the pattern resulted from site aggregation, we compared incidence and mortality distributions by site.

Risk and survival Kaplan-Meier curves

To assess the vulnerability of the coral community to SCTLD during the epizootic, Kaplan-Meier risk and survival curves were calculated for all susceptible species, as well as for each susceptibility group using the survival R package [54]. This aimed to determine the likelihood of exhibiting SCTLD signs during the epizootic (epizootic risk), the overall survival probability of the population, and the survival probability specifically among the affected population. Curves were estimated using the time in days to event occurrence (death or disease) and considering censored cases, i.e., cases in which the event has not occurred during study period, either because they remain healthy to the end of study, or they are not found from a certain moment. Survival probabilities were calculated by:

S(t)= S(t1)*(1Cn) (5)

where (S(t-1)) is the survival probability at the immediately preceding time point, (C) is the number of cases (deaths) at the current time, and (n) is the number of individuals at risk at that time point. In parallel, the probability of becoming diseased (epidemic risk) was calculated as:

R=1S(t) (6)

where (C) now represents new disease cases. In both cases, censored individuals are included in (n) up to the time of censoring, after which they are removed from the set of at-risk individuals. To test significant differences between groups, a 95% CI for each curve, and a Log-rank test were performed. If differences were found, a post hoc pairwise comparison was implemented with the Log-rank test, using the Benjamini-Hochberg method for adjusting p-values with the survminer R package [55].

Prevalence and mortality

Furthermore, daily prevalence and cumulative mortality were calculated and plotted to track their changes throughout the epizootic, and to compare these trends with the epidemic curves. Prevalence was calculated daily as:

P=dn+d*100 (7)

where (d) is the number of diseased individuals on the day, and (n) is the total number individuals at risk on the same day. Cumulative mortality was calculated daily as:

M=DT*100 (8)

where (D) is the total number of cumulated individuals dead by SCTLD, and (T) is the total number of individuals (deaths included).

Species susceptibility to SCTLD

In coral diseases ecology, susceptibility is commonly defined as the likelihood of corals becoming diseased or dying due to specific stressor, and prevalence is a common (and perhaps the most frequent) measure to indicate it at the population and community levels [56,57]. However, prevalence reflects only the proportion of diseased individuals at a given time, and it does not capture the temporal variability of disease risk. While often interpreted as the probability of becoming ill (i.e., epizootic risk), prevalence more accurately represents the probability of finding a diseased individual within the population. Therefore, to better characterize species vulnerability to SCTLD during the epizootic, we employed ten indicators, derived from the epi-curves, prevalence, mortality, and survival analysis. These metrics encompass the onset, progression, and cumulative impact of the outbreak for each coral species.

Susceptibility at the beginning of the epizootic

The start of the SCTLD outbreak in our study was defined as the date of the first diseased individual observed. To determine the sequence of appearance of SCTLD between species, the time elapsed between the start of the SCTLD outbreak, and the first diseased individual of each species was calculated (time at first). This metric has been used to infer relative susceptibility, assuming that species showing signs earlier are more vulnerable [23,30].

In parallel, we estimated the time at which each species reached a prevalence of 5%, which we used as a population-level reference to compare detection dynamics. This value is informed by historical patterns in the Caribbean, where coral diseases typically remain below 5% under endemic conditions [58]. We hypothesize that traditional sampling methods tend to detect disease only after it exceeds such visibility thresholds, rather than capturing the earliest affected colonies.

Susceptibility during the progression of epizootic

To assess species-specific susceptibility throughout the epizootic, we calculated three metrics:

  • -Outbreak length: Time between the first and last observed case per species.

  • -Time to peak: Days from outbreak onset to the species-specific peak.

  • -Height of peak: Proportion of new cases at peak time relative to the population at risk, calculated as:

I=Ipn+Ip*100 (9)

where (Ip) is the number of new cases at the peak, and (n) is the number of individuals at risk at that time.

Cumulative impact after epizootic

To evaluate the overall impact and severity across coral populations, we calculated:

  • -Epizootic risk at end (Kaplan-Meier estimates).

  • -Population and Diseased survival probabilities at end (Kaplan-Meier estimates).

  • -Period prevalence (Pp), adjusted for censored individuals using species-specific risk estimates:

Pp=Td+(c*R)N*100 (10)

-Total mortality (M), incorporating expected deaths among censored individuals:

M=TD+(d*S)N*100 (11)

where (Td) and (TD) are the observed diseased and dead individuals, (c) and (d) are the censored individuals and expected diseased among them, (R) is the estimated risk, (S) is the probability of death among diseased individuals, and (N) is the initial sample size.

To test for species-level differences, we applied Kruskal-Wallis tests followed by Dunn post hoc comparisons. Species associations across metrics were visualized via Principal Component Analysis (PCA), performed using the factoextra R package. All variables were centered (subtracting the mean) and scaled to unit variance (dividing by the standard deviation) prior to analysis to ensure equal contribution to the principal components regardless of their original units or ranges. Eusmilia fastigiata was excluded due to its low sample size (N = 1).

Results

Epizootic progression

The progression of SCTLD epizootic was analyzed using epi-curves (Fig 2) based on 422 coral colonies affected across 16 susceptible species. In addition, epi-curves were produced for all species together and separately in three groups of species based on their expected levels of susceptibility: high, intermediate and low (Fig 3; as noted by [30] and [33]). Species in each susceptibility group are shown in Table 1.

Fig 2. Epi-curves and daily prevalence curves by species through the epizootic.

Fig 2

Incidence is presented weekly in colored bars (showing their expected susceptibility) with values on the primary axis. Sample sizes (N) per species are reported in Table 1. Red vertical lines mark the time of the epizootic peak for each species. Dotted black lines show the daily prevalence curve. Dashed black lines show the cumulative mortality percentage. Blue continuous lines show the proportion of the population at risk. These three proportions have scale on the secondary axis. Climbs on population at risk curves are due to recoveries while decreases after epi-curves’ end are due to adjustments on population at risk proportion by censoring.

Fig 3. Epi-curves grouping species.

Fig 3

A) All susceptible species contrasted by susceptibility groups. All groups started with signs within the first month. Mean weekly temperature (°C) is marked by a solid black line (scale on the secondary axe). B-D) Epi-curves by susceptibility group: B) high, C) intermediate, and D) low susceptibility. Weekly incidence and time in days are in the Y and X axis, respectively. Species in AGRRA code. Red dashed lines mark the epizootic peak.

The progression of the epizootic began with a colony of Pseudodiploria clivosa (N = 5), estimated as the first diseased individual. The onset time and duration of the outbreak varied among coral species. Intermediate and low susceptibility species, such as Siderastrea siderea (N = 211), Agaricia agaricites (N = 255) and Porites astreoides (N = 101), developed signs earlier than some high susceptibility species like Colpophyllia natans (N = 17). In C. natans, P. strigosa (N = 198), Orbicella faveolata (N = 36), S. siderea and A. agaricites the epi-curves exhibited a positive skew, with the central location to the left and the tail extending to the right, indicating a rapid initial spread. Dichocoenia stokesii (N = 6), Meandrina jacksoni (N = 2), P. clivosa and Orbicella annularis (N = 12) also had a positive skew but with a limited number of cases. Conversely, P. astreoides, showed a negative skew, suggesting a slower increase of cases. Agaricia tenuifolia (N = 46), Montastraea cavernosa (N = 56), and Stephanocoenia intersepta (N = 18) displayed a more dispersed distribution of cases over time. Isophyllia sinuosa (N = 8) and Porites porites (N = 18) each had only one case, occurring around the mid- and late-epizootic, respectively. For all species, except P. astreoides, peak occurrences were within the first few weeks of their epi-curves, but with varying times from the beginning of the epizootic (Table 1). Lastly, species with right-skewed epi-curves experienced a prolonged decline in cases, characterized by multiple waves (Fig 2). It is important to note that outbreak duration and curve shape may be influenced by sample size, particularly in species with limited representation.

When analyzing the curves by susceptibility group, all epidemic curves exhibited positive skewness with a prolonged tail to the right (Fig 3B-D). Cases in each susceptibility group began as early as the first month of the outbreak. A Kruskal-Wallis (K-W) test indicated that the timing of the onset of the first diseased colony was independent of the species group (K-W test, p = 0.08). In contrast, the species sequence based on 5% prevalence time showed significant differences between species groups (K-W test, p = 0.003). However, a pairwise post hoc analysis revealed differences only between the high-susceptibility and low-susceptibility groups (Dunn test, p = 0.002). Similarly, the time to epizootic peak was significantly different only between the high and low susceptibility groups (post hoc Dunn test, p = 0.02), with a difference of only over a month between peaks. No association between susceptibility groups and outbreak duration was detected (K-W test, p = 0.91), a result further explored in the discussion.

Combining data from all species reveals a curve slightly skewed to the left, with the peak observed at 99 days from the onset (Fig 3A). The presence of multiple waves following the peak, along with an approximately similar distribution of cases across all susceptibility groups, is particularly notable. When comparing the density distributions of daily incidence and mortality, we found that, after the epizootic peak, increases in mortality precede secondary waves, both in the combined data and in the separate data from each site (Fig 4).

Fig 4. Comparison of the density distributions of daily incidence and mortality during the SCTLD epizootic.

Fig 4

A) Both sites; B) Picudas site; and C) Bocana site. Every site presents around five minor waves of incidence (blue) preceded each by a peak of mortality (red), each signaled by a pair of arrows in blue and red, respectively.

Vulnerability of the coral community

The vulnerability of the coral community to SCTLD was assessed using Kaplan-Meier risk and survival curves, calculated for all susceptible species (S3 and S4 Figs, respectively) and for each susceptibility group (Fig 5A-C). The results revealed that species generally exhibited vulnerability consistent with their susceptibility groups. Species within the high susceptibility group were the most vulnerable, reaching higher risk levels more rapidly and exhibiting near-zero survival probabilities for both at-risk and diseased populations, except for P. clivosa which never reached the 50% risk probability. Interestingly S. siderea, despite belonging to the intermediate susceptibility group, showed a 76% risk probability and very low survival probabilities (under 15%) by the end of the epizootic. Despite showing moderate to high survival probabilities in their at-risk populations (S4 Fig), the species A. agaricites, A. tenuifolia, I. sinuosa, S. intersepta, and P. porites exhibited notably low survival (below 11%) in their diseased populations.

Fig 5. Kaplan-Meyer Risk and Survival curves for the susceptibility species groups.

Fig 5

A) Risk curve showing the probability of disease over time. B) Survival probabilities for all individuals and C) Survival only of those with SCTLD. Dashed lines mark when 50% experienced the event. Shaded ribbons represent 95% confidence intervals. P-values from log-rank tests: χ² = 263, 297, and 63.1, respectively. Data is shown up to day 600 since outbreak onset. In B and C, decreases in survival probabilities occurred beyond day 600 are depicted as vertically dashed lines. These lines do not indicate sudden drops at that point but summarize posterior mortality up to 2.8 years.

Despite these exceptions, comparison of the three risk curves showed significant differences between all species groups (Fig 5A; Log-rank test, p < 0.0001), further supported by post hoc pairwise comparisons (p < 0.001). Despite these differences, there was an overlap in the risk curves for high and intermediate susceptibility groups between September and December 2018, both reaching 50% risk around the first week of November 2018. Contrastingly, the low susceptibility group never reached a 25% risk.

Survival probability curves differed significantly among susceptibility groups for both the populations at risk and the diseased populations (Log rang test: p < 0.0001; pairwise post hoc: p < 0.001), with lower survival in the high susceptibility. However, differences among diseased populations were smaller (χ2 = 62.5 vs. 296; Fig 5C), and by the end of the follow-up, when all unrecovered colonies had died, no significant differences remained (K–W test, p = 0.22).

Magnitude & Severity of epizootic

The impact of the SCTLD epizootic on coral populations was assessed by period prevalence, cumulative mortality and peak incidence rate (height of peak; Table 1). Although daily prevalence curves increased toward the end of the outbreak in all species, this rise is partly driven by the declining number of at-risk colonies (Fig. 2), including censored individuals, which inflates daily prevalence values. Therefore, period prevalence was used as a more reliable measure of epizootic magnitude during the final phase.

The high-susceptibility species were the most affected, with the higher peak heights, period prevalence over 93%, and cumulative mortality above 91%. Except P. clivosa, which had 60% in both metrics. Interestingly, S. siderea, an intermediate susceptibility species, exhibited high period prevalence and mortality (90% and 84%, respectively) (Table 1).

All magnitude and severity metrics showed significant differences only between high and low susceptibility groups (pairwise post hoc Dunn test, p < 0.05).

SCTLD species susceptibility

As previously stated, no consistent differences were observed in the progression of the epizootic among affected species. However, differences in species susceptibility to SCTLD became evident when considering risk, magnitude, and severity. When species were grouped based on their expected susceptibility, more distinct patterns emerged (Fig 5). In contrast, ungrouped analyses revealed greater variability in species responses (S3 and S4 Figs; Table 1), particularly within the intermediate-susceptibility group.

To achieve a more comprehensive understanding of species susceptibility, we integrated the assessed epidemiological parameters (Table 1) using a principal component analysis (PCA, Fig 6). This multivariate approach enabled us to position species along a susceptibility gradient, divided into four vertical segments (Levels I–IV) from right (highest susceptibility) to left (lowest). We based this classification on the horizontal axis (PC1), which explains 60.9% of the total variance and captures the widest distribution of susceptibility-related indicators (e.g., risk, survival, mortality, prevalence). In contrast, the vertical axis (PC2) is primarily influenced by outbreak duration, a variable that may be confounded by species abundance. Therefore, we avoided quadrant-based classification, which could misrepresent susceptibility in species with longer outbreaks but higher population sizes. Overall, the distinction between highly and low susceptible species was largely consistent across the gradient. Nevertheless, the species S. siderea (intermediate expected susceptibility), A. tenuifolia and A. agaricites (both low expected susceptibility) demonstrated a tendency towards increased susceptibility, highlighting the value of integrating multiple indicators.

Fig 6. Principal component analysis (PCA) of ten SCTLD epizootic indicators across coral species.

Fig 6

Species are grouped into colored polygons based on their expected susceptibility: red (High), yellow (Intermediate), and blue (Low). Roman numerals indicate exploratory susceptibility levels derived from the visual distribution of species in PCA space. Higher susceptibility is positioned towards the right along PC1. Species names in AGRRA code.

Below, we summarize the characteristics of each PCA-derived susceptibility level:

Level I: (D. stokesii, M. jacksoni, C. natans and P. strigosa): Early onset and rapid progression to epizootic levels. High total prevalence and mortality. Risk near 100%, survival near 0%. Outbreak length varies with population size; shorter outbreaks show higher peaks and faster spread, while longer outbreaks exhibit lower peaks and multiple transmission waves.

Level II: (S. siderea, P. clivosa and M. cavernosa): Early to intermediate onset. Moderate to high total prevalence, mortality and risk. Low survival of the diseased population but moderated survival of the general population. Early peak time with intermediate peak height. Initial rapid spread followed by prolonged transmission.

Level III: (O. annularis, O. faveolata, S. intersepta, A. tenuifolia, and A. agaricites): Variable onset progression. Moderated total prevalence and mortality. Intermediate to low risk. Moderate to high population survival but reduced survival of diseased individuals (except for O. annularis, O. faveolata). Variable outbreak length related to population size; shorter outbreaks show higher peaks; longer outbreaks show slower spread.

Level IV: (P. astreoides, P. porites and I. sinuosa): Late onset and low mortality and total prevalence. Very low risk and high population survival. Variable outbreak length related to the population size. Short peak height in all cases.

Discussion

In this study, we integrated epidemiological tools widely applied in other systems but largely overlooked in coral epizootic research, to increase our understanding of the temporal dynamics of the SCTLD epizootic. This approach enabled us to determine that species-specific susceptibility was associated with the risk, magnitude, and severity of the epizootic, but not with its progression. We outline a four-level framework of coral susceptibility to SCTLD based on diverse epidemic indicators, rather than solely on prevalence measures. This framework revealed a higher-than-expected susceptibility in S. siderea, A. agaricites and A. tenuifolia. Moreover, by examining the detailed progression of the epizootic, we identified that secondary waves were preceded by increases in mortality. These findings highlight the importance of comprehensive epidemiological studies in investigating coral disease dynamics. Overall, our results contribute to assessing coral community vulnerability during epizootics, interpreting epidemic curves, and exploring their implications for the etiology of this coral syndrome.

Evaluating the vulnerability of coral community during epizootics

One of the most significant findings of this study is that species susceptibility to SCTLD was reflected in the epidemic´s risk, magnitude and severity, but not in its temporal progression. This became more evident when comparing epi-curves across susceptibility groups. In this regard, previous studies have often interpreted the sequence of disease onset as a proxy for susceptibility [33,59]; however, our data show that several intermediate- and low- susceptibility species exhibited signs earlier than some highly susceptible ones.

Interestingly, when analyzing the time to reach 5% prevalence, our results aligned more closely with species-specific onset patterns reported in earlier work [30]. This may reflect variations in sample size, species composition at each site, and the spatial distribution of cases, as traditional sampling methods have demonstrated low accuracy in detecting coral diseases [60]. In contrast, our study employed a comprehensive sampling approach, covering approximately 1100 m2 per site, whereas SCTLD studies typically cover areas of 20–200 m2 [7,23,25,61,62]. Thus, intermediate and low susceptibility species might not have been detected until their populations reached epizootic levels.

Another key aspect emphasized in this study is the limited attention given to the progression of coral epizootics. Most studies on coral diseases assess population or community vulnerability using prevalence-based metrics [32,35,44,63]. However, our results indicate that prevalence may not be a reliable measure of species susceptibility during epizootics (Fig 1). To explore this further, we sub-sampled daily prevalence at days 100, 200, 300, 400, 500, and 600, comparing values among species (S5 Fig). We found that, even if the epizootic started at roughly the same time across populations, prevalence comparisons differed at each time point. This effect would likely be more pronounced between populations from different places.

Therefore, determining coral susceptibility should involve more than assessing population-level impact. When integrating multiple epizootic measures, such as progression, risk, magnitude, and severity, some differences are observed with respect to the expected patterns (Fig 6). Notably, S. siderea, A. agaricites, and A. tenuifolia showed greater vulnerability than previous reported [8,29]. These species, particularly S. siderea, have exhibited variability in prevalence reports (e.g., [24,63]), which may reflect environmental variation, regional stress histories [33], the presence of multiple lineages [6466], co-occurrence of multiple pathologies [67], or the application of a more comprehensive methodology in this study.

Another important aspect to consider is that in all high-susceptibility species analyzed in this study (except P. clivosa), the cessation of the outbreak may be associated with the depletion of the at-risk population (blue lines in Fig 2). In contrast, for species in intermediate- and low-susceptibility groups, where the termination of the outbreak was not due to the depletion of the population at risk but rather to the cessation of transmission. Therefore, we propose that outbreak duration is not a reliable measure of susceptibility in a coral population with low abundance. The cessation of transmission in intermediate- and low-susceptibility species could be explained by the saturation of local susceptible individuals [68]. That is, as corals die, the density of susceptible individuals decreases, limiting further transmission [69]. However, previous studies have observed the development of SCTLD independently of coral [25,26]. Therefore, it appears that unaffected colonies demonstrated greater resistance to SCTLD.

Insights from epizootic curves into the etiology of SCTLD

The shape of the epi-curve with all species combined (Fig 3A and Fig 4A), suggests that the SCTLD epizootic may be linked to exposure from a common point source with potential secondary transmission events [41,43]. Assuming rapid transmission facilitated by currents [53], simultaneous exposure could explain the temporal alignment of onset and peak across susceptibility groups. Williams et al. [23] reported a similar alignment of epizootic peaks across different reef zones in the Lower Florida Keys, despite differences in onset timing, suggesting that similar patterns may occur at other SCTLD-affected sites.

Interestingly, secondary transmission events appear related to mortality, as we have found that increases in mortality preceded secondary waves of the epizootic after the epizootic peak. This pattern was consistent across sites (Fig 4B, C). Previously, it has been raised that the dispersal of SCTLD could be favored by the sloughed tissue coming from dying colonies, as it is potentially loaded with microorganisms [15,33,53]. While our findings do not constitute direct field evidence, they provide model-based support for this hypothesis. Further investigation is needed to establish causality, but the observed patterns are consistent with a potential feedback loop in which coral tissue mortality contributes to increase transmission, thereby aggravating and prolonging the epizootic. This feedback loop has the potential to serve as a transmission mechanism and could even shed light on the origin of the epizootic.

This result could imply both the existence of a primary pathogen and opportunistic infections driven by the large amount of tissue shed from dead corals. Several bacterial types and viral infections of symbiotic algae have been proposed as potential etiological agents of the SCTLD (e.g., [1317,7072]). However, their diversity, variability across sites and host [18,21,33], combined with their absence of direct involvement in tissue damage as evidenced by histopathological analyses [1920], indicate they may act opportunistically [20,21,71]. Such microbial complexity could explain the variability in histopathological lesions observed across outbreaks [19,20,73], potentially reflecting differences in microbial exposure, dysbiosis, or secondary infections that influence the clinical presentation of SCTLD.

On the other hand, in the person-to-person mode of transmission in human epidemics, intervals between epi-curve crests often correspond to incubation periods [41]. In our curves, intervals between waves were approximately 6–13 weeks. But, assuming the role of mortality in producing secondary waves, the lag between mortality peaks and subsequent wave crests was 2–4 weeks. However, in experimental assays, incubation periods ranging from 4–20 days [27,74]. These differences could be due to the complex interactions between hosts (holobiont), pathogens and their environment at the reef scale, which are difficult to reproduce experimentally. This suggests that SCTLD transmission may not follow colony to colony dispersal but rather exposure from a common source, consistent with findings that SCTLD epizootics may not rely on colony density [25,26].

Additionally, while not mutually exclusive, this phenomenon may be linked to variations in environmental conditions, such as annual temperature patterns or thermal anomalies. Our findings suggest a positive correlation between the increase in cases and rising temperatures, alongside a decline in cases during the main wave with the onset of winter (Fig 3A). Conversely, secondary waves began to emerge starting in the winter months. Further research is required to investigate the potential relationship between our data and thermal anomalies. Notably, in other regions, the association between SCTLD and temperature has been inconclusive, with both positive [7,31] and negative [10,23] correlations reported in relation to the epizootic’s progression. These findings suggest that the susceptibility of coral to disease may be influenced by a range of environmental factors, not limited to elevated temperatures. In the other hand

However, if all coral colonies were exposed to SCTLD agents simultaneously, as suggested by our observations, the variation in disease risk among species implies that susceptibility is modulated by intrinsic biological or ecological factors. This variability in the susceptibility of corals has indeed been observed within populations of the same species [26,75], and inclusively between clonal individuals [76]. Resistance or susceptibility could be mediated by the size and morphology of coral colonies [75]. More recently, it has been suggested that the type of symbiont (genus) dominant in a coral species or individuals may be very closely related to susceptibility to SCTLD. For instance, intraspecific susceptibility in O. faveolata has been found to be more closely linked to the genus of the symbiont rather than the genotype of the host [76]. Furthermore, a hierarchy of susceptibility to SCTLD has been observed among symbiont genera [77]. Histopathologic analyses have observed that the first tissue layer affected is the gastrodermis, where algal symbionts reside [19,20]. Beavers et al. [78] observed that SCTLD-affected colonies phagocytize dysfunctional symbionts. They propose that viral infections of symbiont algae trigger immune responses against affected symbionts or their pathogens, where the symbiont genera show a differential resistance to infection and degradation. However, more research is needed to state the role of viruses as primary causative agents or opportunistic pathogens [21,33].

Opportunistic infections may contribute to the onset of the epizootic through diverse, non-exclusive pathways. A substantial influx of microorganisms, pathogenic or not, can induce tissue necrosis by colonizing lesions or being ingested [79]. Additionally, they may alter and disrupt microbial assemblages in the coral’s mucus layer [20], leading to dysbiosis and the development of opportunistic infections within the microbiome [8082]. These conditions may trigger immune responses such as peroxidase activity, melanization, and apoptosis, as documented in SCTLD [33,83]. Which, when dysregulated, exacerbate tissue damage and destabilize coral-algal symbiosis [84]. Corals hosting stress-tolerant symbionts may be more likely to recover due to preserved nutritional resources.

An outbreak caused by opportunistic microorganisms traveling in the organic matter detached from dead corals, does not contradict the possibility of large-scale contagious dispersal favored by the marine currents [22,53]. Further research is necessary to elucidate the dispersal patterns of SCTLD at a regional scale within the Mexican Caribbean. Additionally, potential sources of dispersion such as transport from Florida reefs [22], discharge from ballast water [24,85] and resuspended sediments [74] should be carefully considered.

Methodological considerations and limitations

This study presents several methodological considerations: Variation in sample sizes across species, may influence the shape and duration of epidemic curves, particularly in underrepresented taxa. However, near-complete censuses within defined survey areas, recording all visible coral colonies regardless of species or condition, minimized sampling bias and reduced the likelihood of abundance-driven artefacts. Notably, M. jacksoni (N = 2) and D. stokesii (N = 6) showed extreme susceptibility (100% prevalence, mortality, and risk), consistent with reports from other regions [30,33], while other low-abundance species such as P. porites (N = 18) and I. sinuosa (N = 8) exhibited much lower susceptibility (<13%). These patterns suggest that species-level vulnerability reflects intrinsic biological differences rather than sample size or visibility; For colonies with only one recorded observation of tissue loss, inference-based approaches (III and IV, see methods) were applied transparently, incorporating ecological indicators and uncertainty. Among these single-record cases, the distribution across susceptibility groups was approximately balanced (57% high, 44.5% intermediate, 62% low; relative to diseased colonies in each group), suggesting no systematic bias toward any group. A more influential factor was colony size: 61% of these cases corresponded to small colonies. We consider that this approach adds value by recovering information that would otherwise be excluded and by enabling the inclusion of these cases in broader epidemiological analyses; To improve temporal resolution, data from two nearby sites were pooled under the assumption of non-density-dependent dynamics, enhancing curve continuity while potentially obscuring fine-scale spatial patterns; Finally, extrapolation of tissue loss timing via algal colonization did not account for skeletal morphology, though environmental conditions were assumed to dominate secondary succession.

Perspectives and implications

This study highlights the value of epidemic curves as a central tool for characterizing coral disease dynamics. Their ability to capture the temporal structure of outbreaks makes them especially useful for detecting shifts in disease behavior and identifying outbreaks that may escalate into epizootics. Given their ease of implementation and interpretability, epi-curves can be integrated into routine monitoring programs to provide real-time insights and support timely decisions on surveillance, containment, and restoration. When combined with risk-based indicators, they offer a robust framework for adaptive management, helping practitioners anticipate critical transitions and prioritize interventions. Although applied here during an active outbreak, this approach can be extended to long-term monitoring, generating high-resolution temporal data that reveals subtle changes in disease dynamics and enable links to environmental or anthropogenic drivers. Moreover, the use of epidemic curves and integrated indicators is scalable to other coral diseases and marine taxa affected by epizootic events. As SCTLD continues to expand across the Caribbean, these tools could enhance regional coordination, optimize resource allocation, and strengthen conservation responses.

Conclusions

This study demonstrates the value and utility of epizootic curves for investigating coral disease epidemics, offering a significant advantage over other commonly applied tools, such as prevalence measurements. By integrating this approach with assessments of the risk, magnitude, and severity of the epizootic, we were able to explore relevant aspects of its progression, generate insights into the potential etiology of SCTLD, and examine patterns of species-specific susceptibility. Notably, species-specific susceptibility was found to influence the risk, magnitude, and severity of the epizootic, although it did not affect its progression. This comprehensive, fine-grained methodology also revealed greater susceptibility in certain species that had previously been underestimated. Finally, this study provides evidence of a possible feedback loop acting in the SCTLD epizootic, which has never been described before. Based on these results, we strongly recommend integrating diverse epidemiological evidence, particularly epidemic curves, into current monitoring efforts. Additionally, we suggest investigating whether an epizootic progression pattern similar to the one observed here has occurred at other sites affected by SCTLD, and other coral diseases or syndromes.

Supporting information

S1 Fig. Estimation of lesion progression for colonies with only one recorded tissue loss value.

Example for P. strigosa (medium size, acute lesion progression, n = 12): A) Daily tissue loss trajectories from colonies with multiple observations were grouped by species, size category, and lesion progression type. Each colored line is an individual trajectory. B) Time was normalized around the 50% tissue loss point to align trajectories and estimate average trajectory. C) The average trajectory (blue line) and its 95% confidence interval (blue ribbon) were computed via bootstrap percentile method. D) Red dots show single-record colonies; their lesion progression was extrapolated using the reference trajectory, assuming similar dynamics.

(PDF)

pone.0339054.s001.pdf (18.1MB, pdf)
S2 Fig. Identification of the stages of colonization of the denuded coral skeleton by SCTLD.

Process illustrated with two colonies of P. strigosa. Dual view per colony: natural appearance (top) and colonization stage overlays (bottom). Legend at the lower right corner. Colonization stages are arranged outward from the living tissue and delineated by distinct line patterns in the following order: Recently dead (almost pure white coloration), Film 1 (incipient microbial film), Film 2 (well-established microbial biofilm; denser algal films with more saturated hues), Film 3 (incipient algal mat; filamentous algae beginning to establish, with possible sediment entrapment), Turf algae (denser mats of juvenile macroalgae or filamentous algae), and Macroalgae (advanced macroalgal growth, often identifiable to genus level).

(PDF)

pone.0339054.s002.pdf (20.3MB, pdf)
S3 Fig. Probability of becoming diseased by species.

Colored bands represent the 95% Confidence Interval. Colors indicate the expected susceptibility groups: red for high susceptibility, yellow for medium susceptibility, and blue for low susceptibility. A notable decrease in risk is observed as one moves to lower levels of expected susceptibility. However, some species, such as P. clivosa, S. siderea, and S. intersepta, display values that deviate from their expected susceptibility groups. Overall, the medium susceptibility group exhibited greater heterogeneity.

(PDF)

pone.0339054.s003.pdf (423.6KB, pdf)
S4 Fig. Kaplan-Meier survival probability curves for the population (blue lines) and diseased individuals (red lines) by species.

Bands represent the 95% Confidence Interval. For clarity, graphs display data up to day 600 from the outbreak onset. Decreases in survival probabilities occurred beyond day 600 are depicted as vertically dashed lines. These lines do not indicate sudden drops at that point but summarize posterior mortality up to 2.8 years.

(PDF)

pone.0339054.s004.pdf (50.4KB, pdf)
S5 Fig. Sub-sampling of prevalence of SCTLD by species at 100, 200, 300, 400, 500 and 600 days from the onset of epizootic.

Colors show the expected susceptibility group: High (red), Intermediate (yellow), and Low (blue). Panels show that prevalence comparisons between species differed at each time point. Furthermore, the prevalence levels of species mostly failed to match the expected susceptibility patterns across the sub-sampled periods.

(PDF)

pone.0339054.s005.pdf (678.3KB, pdf)
S1 Table. Frequency of use of parameters to classify species susceptibility to SCTLD.

(PDF)

pone.0339054.s006.pdf (140.6KB, pdf)
S2 Table. Web of Science studies about coral epizootics from 1995 to 2025.

(XLSX)

pone.0339054.s007.xlsx (88.7KB, xlsx)
S3 Table. GAMM’s models validation.

The table shows the results of the normality, homoscedasticity, and autocorrelation tests on the residuals, as well as the model fit (R² values).

(XLSX)

pone.0339054.s008.xlsx (28KB, xlsx)
S4 Table. Onset and complete mortality days calculation through average tissue loss rates.

(XLSX)

pone.0339054.s009.xlsx (27.7KB, xlsx)
S5 Table. Mean time of change from apparently healthy tissue adjacent to any lesion to each stage of colonization.

Status codes: Recently dead, denotes recently denuded skeleton; Film 1 is a scarce microbial/algal film; Film 2 is a well-stablished biofilm; Film 3 incipient turf algae mats; Turf Algae, denser turf algae mats; Macro Algae, macroalgal patches identifiable to genus level. (n) is the number of colonies analyzed to time calculations. CI = Confidence Interval of the 95%.

(PDF)

pone.0339054.s010.pdf (94.3KB, pdf)
S1 Dataset. Complete dataset. Containing dates and times of onset and mortality or recovery, size, type of lesion progression, and expected susceptibility of each colony.

(XLSX)

pone.0339054.s011.xlsx (81.3KB, xlsx)

Acknowledgments

We thank the Posgrado en Ciencias del Mar y Limnología at UNAM for academic support leading to the doctoral degree of EOG-U. We acknowledge J. Rivera Ortega and R. Rodríguez Martínez for their invaluable assistance with monitoring; to E. Escalante Mancera and M. A. Gómez Reali from Meteorological and Oceanographic Monitoring Academic Service in Puerto Morelos for providing SST data; to E. Pérez Cervantes for technical support in BARCO lab; and F. Negrete Soto for his support with boat operations and diving logistics.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

All the sources of support received during this study were: The Institute of Marine Sciences and Limnology (ICMyL) and the National Autonomous University of Mexico (UNAM) providing financial and logistic support to EJ-D; Mexican Council of Science and Technology (CONACYT) grant the doctoral scholarship granted to EOG-U (895565), and a research grant awarded to LA-F (FORDECYT-PRONACES/425888/2020). ICMyL: https://www.icmyl.unam.mx/ UNAM: https://www.unam.mx/ CONACYT: https://secihti.mx/becas_posgrados/ There was no additional external funding received for this study.

References

  • 1.Knowlton N, Brainard RE, Fisher R, Moews M, Plaisance L, Caley MJ. Coral Reef Biodiversity. In: McIntyre AD, editor. Life in the World’s Oceans. Blackwell Publishing Ltd. 2010. p. 65–77. [Google Scholar]
  • 2.Costanza R, de Groot R, Sutton P, van der Ploeg S, Anderson SJ, Kubiszewski I, et al. Changes in the global value of ecosystem services. Global Environmental Change. 2014;26:152–8. doi: 10.1016/j.gloenvcha.2014.04.002 [DOI] [Google Scholar]
  • 3.Vega-Thurber R, Mydlarz LD, Brandt M, Harvell D, Weil E, Raymundo L, et al. Deciphering coral disease dynamics: integrating host, microbiome, and the changing environment. frontiers in ecology and evolution. Front Media S.A. 2020; 8(575927):1–18. [Google Scholar]
  • 4.Maynard J, Van Hooidonk R, Eakin CM, Puotinen M, Garren M, Williams G. Projections of climate conditions that increase coral disease susceptibility and pathogen abundance and virulence. Nat Clim Chang. 2015;5(7):688–94. [Google Scholar]
  • 5.Zhao H, Yuan M, Strokal M, Wu HC, Liu X, Murk A, et al. Impacts of nitrogen pollution on corals in the context of global climate change and potential strategies to conserve coral reefs. Sci Total Environ. 2021;774:145017. doi: 10.1016/j.scitotenv.2021.145017 [DOI] [Google Scholar]
  • 6.Roth L, Kramer PR, Doyle E, O’Sullivan C. Caribbean SCTLD Dashboard. https://www.agrra.org/coral-disease-outbreak/. 2020. Accessed 2025 June.
  • 7.Precht WF, Gintert BE, Robbart ML, Fura R, Van Woesik R. Unprecedented disease-related coral mortality in southeastern Florida. Scientific Reports. 2016;6(31374):1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Alvarez-Filip L, Estrada-Saldívar N, Pérez-Cervantes E, Molina-Hernández A, González-Barrios FJ. A rapid spread of the stony coral tissue loss disease outbreak in the Mexican Caribbean. PeerJ. 2019;7:e8069. doi: 10.7717/peerj.8069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Noonan KR, Childress MJ. Association of butterflyfishes and stony coral tissue loss disease in the Florida Keys. Coral Reefs. 2020;39(6):1581–90. doi: 10.1007/s00338-020-01986-8 [DOI] [Google Scholar]
  • 10.Estrada-Saldívar N, Quiroga-García BA, Pérez-Cervantes E, Rivera-Garibay OO, Alvarez-Filip L. Effects of the stony coral tissue loss disease outbreak on coral communities and the benthic composition of cozumel reefs. Front Mar Sci. 2021;8(39):861–6. [Google Scholar]
  • 11.Heres MM, Farmer BH, Elmer F, Hertler H. Ecological consequences of stony coral tissue loss disease in the Turks and Caicos Islands. Coral Reefs. 2021;40(2):609–24. doi: 10.1007/s00338-021-02071-4 [DOI] [Google Scholar]
  • 12.Molina-Hernández A, Medellín-Maldonado F, Lange ID, Perry CT, Álvarez-Filip L. Coral reef erosion: In situ measurement on different dead coral substrates on a Caribbean reef. Limnol Oceanogr. 2022;67(12):2734–49. [Google Scholar]
  • 13.Meyer JL, Castellanos-Gell J, Aeby GS, Häse CC, Ushijima B, Paul VJ. Microbial community shifts associated with the ongoing stony coral tissue loss disease outbreak on the Florida reef tract. Front Microbiol. 2019;10(2244):1–12. doi: 10.3389/fmicb.2019.02244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Paul VJ, Ushijima B, Aeby G. Studies of the Ecology and Microbiology of Florida’s Coral Tissue Loss Diseases. Miami, FL: Florida DEP. 2019. [Google Scholar]
  • 15.Aeby GS, Ushijima B, Campbell JE, Jones S, Williams GJ, Meyer JL. Pathogenesis of a tissue loss disease affecting multiple species of corals along the Florida reef tract. Frontiers in Marine Science. 2019;6(678):1–18.36817748 [Google Scholar]
  • 16.Rosales SM, Clark AS, Huebner LK, Ruzicka RR, Muller EM. Rhodobacterales and rhizobiales are associated with stony coral tissue loss disease and its suspected sources of transmission. Front Microbiol. 2020;11:681. doi: 10.3389/fmicb.2020.00681 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Work TM, Weatherby TM, Landsberg JH, Kiryu Y, Cook SM, Peters EC. Viral-like particles are associated with endosymbiont pathology in Florida corals affected by stony coral tissue loss disease. Front Mar Sci. 2021;8. doi: 10.3389/fmars.2021.750658 [DOI] [Google Scholar]
  • 18.Veglia AJ, Beavers K, Van Buren EW, Meiling SS, Muller EM, Smith TB, et al. Alphaflexivirus genomes in stony coral tissue loss disease-affected, disease-exposed, and disease-unexposed coral colonies in the U.S. Virgin Islands. Microbiol Resour Announc. 2022;11(2):e0119921. doi: 10.1128/mra.01199-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Landsberg JH, Kiryu Y, Peters EC, Wilson PW, Perry N, Waters Y, et al. Stony coral tissue loss disease in Florida is associated with disruption of host–zooxanthellae physiology. Front Mar Sci. 2020;7. doi: 10.3389/fmars.2020.576013 [DOI] [Google Scholar]
  • 20.Thome PE, Rivera-Ortega J, Rodríguez-Villalobos JC, Cerqueda-García D, Guzmán-Urieta EO, García-Maldonado JQ, et al. Local dynamics of a white syndrome outbreak and changes in the microbial community associated with colonies of the scleractinian brain coral Pseudodiploria strigosa. PeerJ. 2021;9:e10695. doi: 10.7717/peerj.10695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Howe-Kerr LI, Knochel AM, Meyer MD, Sims JA, Karrick CE, Grupstra CGB, et al. Filamentous virus-like particles are present in coral dinoflagellates across genera and ocean basins. ISME J. 2023;17(12):2389–402. doi: 10.1038/s41396-023-01526-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Muller EM, Sartor C, Alcaraz NI, van Woesik R. Spatial epidemiology of the stony-coral-tissue-loss disease in Florida. Front Mar Sci. 2020;7. doi: 10.3389/fmars.2020.00163 [DOI] [Google Scholar]
  • 23.Williams SD, Walter CS, Muller EM. Fine scale temporal and spatial dynamics of the stony coral tissue loss disease outbreak within the lower Florida keys. Front Mar Sci. 2021;8. doi: 10.3389/fmars.2021.631776 [DOI] [Google Scholar]
  • 24.Dahlgren C, Pizarro V, Sherman K, Greene W, Oliver J. Spatial and temporal patterns of stony coral tissue loss disease outbreaks in the bahamas. Front Mar Sci. 2021;8. doi: 10.3389/fmars.2021.682114 [DOI] [Google Scholar]
  • 25.Sharp WC, Shea CP, Maxwell KE, Muller EM, Hunt JH. Evaluating the small-scale epidemiology of the stony-coral -tissue-loss-disease in the middle Florida keys. PLoS One. 2020;15(11):e0241871. doi: 10.1371/journal.pone.0241871 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Guzmán-Urieta EO, Jordán-Dahlgren E. Spatial patterns of a lethal white syndrome outbreak in pseudodiploria strigosa. Front Mar Sci. 2021;8. doi: 10.3389/fmars.2021.669171 [DOI] [Google Scholar]
  • 27.Meiling SS, Muller EM, Lasseigne D, Rossin A, Veglia AJ, MacKnight N, et al. Variable species responses to experimental stony coral tissue loss disease (SCTLD) exposure. Front Mar Sci. 2021;8. doi: 10.3389/fmars.2021.670829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Neely KL, Lewis CL, Lunz KS, Kabay L. Rapid Population decline of the pillar coral dendrogyra cylindrus along the florida reef tract. Front Mar Sci. 2021;8. doi: 10.3389/fmars.2021.656515 [DOI] [Google Scholar]
  • 29.Alvarez-Filip L, González-Barrios FJ, Pérez-Cervantes E, Molina-Hernández A, Estrada-Saldívar N. Stony coral tissue loss disease decimated Caribbean coral populations and reshaped reef functionality. Commun Biol. 2022;5(1):440. doi: 10.1038/s42003-022-03398-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Florida Department of Environmental Protection FDEP. Stony Coral Tissue Loss Disease (SCTLD) Case Definition. 2018. https://floridadep.gov/sites/default/files/Copy%20of%20StonyCoralTissueLossDisease_CaseDefinition%20final%2010022018.pdf
  • 31.Meiling S, Muller EM, Smith TB, Brandt ME. 3D photogrammetry reveals dynamics of stony coral tissue loss disease (SCTLD) lesion progression across a thermal stress event. Front Mar Sci. 2020;7. doi: 10.3389/fmars.2020.597643 [DOI] [Google Scholar]
  • 32.Costa SV, Hibberts SJ, Olive DA, Budd KA, Long AE, Meiling SS, et al. Diversity and disease: the effects of coral diversity on prevalence and impacts of stony coral tissue loss disease in saint thomas, U.S. Virgin Islands. Front Mar Sci. 2021;8. doi: 10.3389/fmars.2021.682688 [DOI] [Google Scholar]
  • 33.Papke E, Carreiro A, Dennison C, Deutsch JM, Isma LM, Meiling SS, et al. Stony coral tissue loss disease: a review of emergence, impacts, etiology, diagnostics, and intervention. Front Mar Sci. 2024;10. doi: 10.3389/fmars.2023.1321271 [DOI] [Google Scholar]
  • 34.Woodley CM, Downs CA, Bruckner AW, Porter JW, Galloway SB, editors. Diseases of coral. Hoboken, New Jersey: Wiley Blackwell. 2016. [Google Scholar]
  • 35.Williams SM, García-Sais J, Sabater-Clavell J. Prevalence of stony coral tissue loss disease at el seco, a mesophotic reef system off Vieques Island, Puerto Rico. Front Mar Sci. 2021;8. doi: 10.3389/fmars.2021.668669 [DOI] [Google Scholar]
  • 36.Rogers CS. Words matter: Recommendations for clarifying coral disease nomenclature and terminology. Dis Aquat Organ. 2010;91(2):167–75. doi: 10.3354/dao02261 [DOI] [PubMed] [Google Scholar]
  • 37.Morabia A. Pandemics and methodological developments in epidemiology history. J Clin Epidemiol. 2020;125:164–9. doi: 10.1016/j.jclinepi.2020.06.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lian M, Warner RD, Alexander JL, Dixon KR. Using geographic information systems and spatial and space-time scan statistics for a population-based risk analysis of the 2002 equine West Nile epidemic in six contiguous regions of Texas. Int J Health Geogr. 2007;6:42. doi: 10.1186/1476-072X-6-42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Shanafelt DW, Jones G, Lima M, Perrings C, Chowell G. Forecasting the 2001 Foot-and-Mouth Disease Epidemic in the UK. Ecohealth. 2018;15(2):338–47. doi: 10.1007/s10393-017-1293-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Torok M. Epidemic Curves Ahead. FOCUS on Field Epidemiology. 2003;1(5):1–6. [Google Scholar]
  • 41.Dicker RC, Coronado F, Koo D, Parrish RG. Principles of epidemiology in public health practice; an introduction to applied epidemiology and biostatistics. 3rd ed. Atlanta, GA: U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. 2006. [Google Scholar]
  • 42.Jang SY, Hussain-Alkhateeb L, Rivera Ramirez T, Al-Aghbari AA, Chackalackal DJ, Cardenas-Sanchez R. Factors shaping the COVID-19 epidemic curve: a multi-country analysis. BMC Infectious Diseases. 2021;21(1032):1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Centers for Disease Control and Prevention CDC. Epidemiologic clues and modes of transmission. https://www.cdc.gov/training/QuickLearns/epimode/. 2025.
  • 44.Web of Science (WOS). https://www.webofscience.com/wos/woscc/summary/40e97fc7-ba9c-48ca-a137-1b150c1feab9-016aacdc46/relevance/1. 2025. Accessed 2025 June 24.
  • 45.Shapiro-Ilan DI, Bruck DJ, Lacey LA. Principles of epizootiology and microbial control. Insect pathology. Second ed. Elsevier. 2012. p. 29–72. [Google Scholar]
  • 46.Work TM, Aeby GS. Systematically describing gross lesions in corals. Dis Aquat Organ. 2006;70(1–2):155–60. doi: 10.3354/dao070155 [DOI] [PubMed] [Google Scholar]
  • 47.Wood SN. Fast Stable Restricted Maximum Likelihood and Marginal Likelihood Estimation of Semiparametric Generalized Linear Models. Journal of the Royal Statistical Society Series B: Statistical Methodology. 2010;73(1):3–36. doi: 10.1111/j.1467-9868.2010.00749.x [DOI] [Google Scholar]
  • 48.Canty A, Ripley B. boot: Bootstrap R (S-Plus) Functions. 2024. [Google Scholar]
  • 49.Fox J, Weisberg S. An R Companion to Applied Regression. 3rd ed. Thousand Oaks CA: Sage. 2019. [Google Scholar]
  • 50.Gross J, Ligges U. Nortest: Tests for Normality. 2015. doi: 10.32614/CRAN.package.nortest [DOI] [Google Scholar]
  • 51.Zeileis A, Hothorn T. Diagnostic checking in regression relationships. R News. 2002;2(3):7–10. [Google Scholar]
  • 52.Jombart T, Kamvar ZN, FitzJohn R, Cai J, Bhatia S, Schumacher J. Incidence: Compute, handle, plot and model incidence of dated events. 2024. [Google Scholar]
  • 53.Dobbelaere T, Muller EM, Gramer LJ, Holstein DM, Hanert E. Coupled Epidemio-Hydrodynamic Modeling to Understand the Spread of a Deadly Coral Disease in Florida. Front Mar Sci. 2020;7. doi: 10.3389/fmars.2020.591881 [DOI] [Google Scholar]
  • 54.Therneau T. A package for survival analysis in R. 2024. [Google Scholar]
  • 55.Kassambara A, Kosinski M, Biecek P. survminer: Drawing Survival Curves using “ggplot2”. CRAN: Contributed Packages. The R Foundation. 2016. doi: 10.32614/cran.package.survminer [DOI] [Google Scholar]
  • 56.Calnan JM, Smith TB, Nemeth RS, Kadison E, Blondeau J. Coral disease prevalence and host susceptibility on mid-depth and deep reefs in the United States Virgin Islands. Rev Biol Trop. 2008;56(1):223–34. [Google Scholar]
  • 57.Hobbs JPA, Frisch AJ. Coral disease in the Indian ocean: Taxonomic susceptibility, spatial distribution and the role of host density on the prevalence of white syndrome. Dis Aquat Organ. 2010;89(1):1–8. [DOI] [PubMed] [Google Scholar]
  • 58.Weil E, Rogers CS. Coral reef diseases in the Atlantic-Caribbean. In: Dubinsky Z, Stambler N, editors. Coral reefs: An ecosystem in transition. 2011. doi: 10.1007/978-94-007-0114-4_27 [DOI] [Google Scholar]
  • 59.Vega Thurber RL, Silva D, Speare L, Croquer A, Veglia AJ, Alvarez-Filip L, et al. Coral Disease: Direct and Indirect Agents, Mechanisms of Disease, and Innovations for Increasing Resistance and Resilience. Ann Rev Mar Sci. 2025;17(1):227–55. doi: 10.1146/annurev-marine-011123-102337 [DOI] [PubMed] [Google Scholar]
  • 60.Jordán-Dahlgren E, Jordán-Garza AG, Rodríguez-Martínez RE. Coral disease prevalence estimation and sampling design. PeerJ. 2018;6:e6006. doi: 10.7717/peerj.6006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Lang JC, Marks KW, Kramer PA, Kramer PR, Ginsburg RN. AGRRA protocols version 5.4. Florida, USA: Atlantic and Gulf Rapid Reef Assessment Program. 2010. [Google Scholar]
  • 62.Walton CJ, Hayes NK, Gilliam DS. Impacts of a regional, multi-year, multi-species coral disease outbreak in Southeast Florida. Front Mar Sci. 2018;5. doi: 10.3389/fmars.2018.00323 [DOI] [Google Scholar]
  • 63.Brandt ME, Ennis RS, Meiling SS, Townsend J, Cobleigh K, Glahn A, et al. The emergence and initial impact of stony coral tissue loss disease (SCTLD) in the United States Virgin Islands. Front Mar Sci. 2021;8. doi: 10.3389/fmars.2021.715329 [DOI] [Google Scholar]
  • 64.Rippe JP, Dixon G, Fuller ZL, Liao Y, Matz M. Environmental specialization and cryptic genetic divergence in two massive coral species from the Florida Keys Reef Tract. Molecular Ecology. 2021;30(14):3468–84. [DOI] [PubMed] [Google Scholar]
  • 65.Aichelman HE, Benson BE, Gomez-Campo K, Isabel Martinez-Rugerio M, Fifer JE, Tsang L. Cryptic coral diversity is associated with symbioses, physiology, and response to thermal challenge. Sci Adv. 2025;11:eadr5237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.López-Villarreal DA. Diversidad genómica de los corales escleractíneos Agaricia agaricites, Montastraea cavernosa y Siderastrea siderea del Caribe Mexicano. Centro de Investigaciones Biológicas del Noroeste, SC. 2024. https://cibnor.repositorioinstitucional.mx/jspui/bitstream/1001/3025/1/lopez_d%20TESIS.pdf [Google Scholar]
  • 67.Aeby GS, Kiryu Y, Landsberg J, Ushijima B, Jones S, Houk LJ, et al. Progressive chronic tissue loss disease in Siderastrea siderea on Florida’s coral reef. PLoS One. 2025;20(8):e0329911. doi: 10.1371/journal.pone.0329911 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Joo J, Lebowitz JL. Behavior of susceptible-infected-susceptible epidemics on heterogeneous networks with saturation. Phys Rev E Stat Nonlin Soft Matter Phys. 2004;69(6 Pt 2):066105. doi: 10.1103/PhysRevE.69.066105 [DOI] [PubMed] [Google Scholar]
  • 69.Thrusfield M. Epidemiology. In: Woodley CM, Downs CA, Bruckner AW, Porter JW, Galloway SB, editors. Diseases of coral. Hoboken, New Jersey: Wiley Blackwell. 2016. p. 28–51. [Google Scholar]
  • 70.Iwanowicz DD, Schill WB, Woodley CM, Bruckner A, Neely K, Briggs KM. Exploring the Stony Coral Tissue Loss Disease Bacterial Pathobiome. Cold Spring Harbor Laboratory. 2020. doi: 10.1101/2020.05.27.120469 [DOI] [Google Scholar]
  • 71.Vega-Thurber RL, Correa AMS. Meta-transcriptomics to determine if and how viruses are involved in SCTLD infection status and/or disease susceptibility. Miami, FL: Florida DEP. 2023. [Google Scholar]
  • 72.Arriaga-Piñón ZP, Aguayo-Leyva JE, Álvarez-Filip L, Banaszak AT, Aguirre-Macedo ML, Paz-García DA, et al. Microbiomes of three coral species in the Mexican Caribbean and their shifts associated with the Stony Coral Tissue Loss Disease. PLoS One. 2024;19(8):e0304925. doi: 10.1371/journal.pone.0304925 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Work TM, Miller J, Kelley T, Hawthorn A, Weatherby T, Rogers CS. Pathology of lesions in corals from the US Virgin Islands after emergence of stony coral tissue loss disease. Coral Reefs. 2024;44(1):179–92. doi: 10.1007/s00338-024-02595-5 [DOI] [Google Scholar]
  • 74.Studivan MS, Rossin AM, Rubin E, Soderberg N, Holstein DM, Enochs IC. Reef Sediments Can Act As a Stony Coral Tissue Loss Disease Vector. Front Mar Sci. 2022;8. doi: 10.3389/fmars.2021.815698 [DOI] [Google Scholar]
  • 75.Camacho-Vite C, Estrada-Saldívar N, Pérez-Cervantes E, Alvarez-Filip L. Differences in the progression rate of SCTLD in Pseudodiploria strigosa are related to colony size and morphology. Front Mar Sci. 2022;9. doi: 10.3389/fmars.2022.790818 [DOI] [Google Scholar]
  • 76.Klein AM, Sturm AB, Eckert RJ, Walker BK, Neely KL, Voss JD. Algal symbiont genera but not coral host genotypes correlate to stony coral tissue loss disease susceptibility among Orbicella faveolata colonies in South Florida. Front Mar Sci. 2024;11. doi: 10.3389/fmars.2024.1287457 [DOI] [Google Scholar]
  • 77.Dennison CE, Karp RF, Weiler BA, Goncalves A, del Campo J, Rosales SM. The role of algal symbionts (genus Breviolum) in the susceptibility of corals to Stony Coral Tissue Loss Disease in South Florida. Miami, FL: Florida DEP. 2021. [Google Scholar]
  • 78.Beavers KM, Van Buren EW, Rossin AM, Emery MA, Veglia AJ, Karrick CE. Stony coral tissue loss disease induces transcriptional signatures of in situ degradation of dysfunctional Symbiodiniaceae. Nature Communications. 2023;14(2915):1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Gavish AR, Shapiro OH, Kramarsky-Winter E, Vardi A. Microscale tracking of coral-vibrio interactions. ISME Commun. 2021;1(1):18. doi: 10.1038/s43705-021-00016-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Rosenberg E, Koren O, Reshef L, Efrony R, Zilber-Rosenberg I. The role of microorganisms in coral health, disease and evolution. Nat Rev Microbiol. 2007;5(5):355–62. doi: 10.1038/nrmicro1635 [DOI] [PubMed] [Google Scholar]
  • 81.Cárdenas A, Rodriguez-R LM, Pizarro V, Cadavid LF, Arévalo-Ferro C. Shifts in bacterial communities of two Caribbean reef-building coral species affected by white plague disease. ISME J. 2012;6(3):502–12. doi: 10.1038/ismej.2011.123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.He X, Zou J, Chen Q, Qin X, Liu Y, Zeng L, et al. Microbial and transcriptional response of Acropora valida and Turbinaria peltata to Vibrio coralliilyticus challenge: insights into corals disease resistance. BMC Microbiol. 2024;24(1):288. doi: 10.1186/s12866-024-03438-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Traylor-Knowles N, Connelly MT, Young BD, Eaton K, Muller EM, Paul VJ. Gene expression response to stony coral tissue loss disease transmission in M. cavernosa and O. faveolata from Florida. Front Marine Sci. 2021;8(681563):1–15. doi: 10.3389/fmars.2021.681563 [DOI] [Google Scholar]
  • 84.Traylor-Knowles N, Baker AC, Beavers KM, Garg N, Guyon JR, Hawthorn A, et al. Advances in coral immunity ‘omics in response to disease outbreaks. Front Mar Sci. 2022;9. doi: 10.3389/fmars.2022.952199 [DOI] [Google Scholar]
  • 85.Studivan MS, Baptist M, Molina V, Riley S, First M, Soderberg N, et al. Transmission of stony coral tissue loss disease (SCTLD) in simulated ballast water confirms the potential for ship-born spread. Sci Rep. 2022;12(1):19248. doi: 10.1038/s41598-022-21868-z [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Parviz Tavakoli-Kolour

10 Sep 2025

Dear Dr. Guzman,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 25 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Parviz Tavakoli-Kolour

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf .

2. Thank you for stating in your Funding Statement:

 “The Institute of Marine Sciences and Limnology (ICMyL) and the National Autonomous University of Mexico (UNAM) providing financial and logistic support to EJ-D; Mexican Council of Science and Technology (CONACYT) grant the doctoral scholarship granted to EG-U (895565), and a research grant awarded to LA-F (FORDECYT-PRONACES/425888/2020).

ICMyL: https://www.icmyl.unam.mx/

UNAM: https://www.unam.mx/

CONACYT: https://secihti.mx/becas_posgrados/” 

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement.

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

3. We note that there is identifying data in the Supporting Information file <S2 Table>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws.

Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared:

-Name, initials, physical address

-Ages more specific than whole numbers

-Internet protocol (IP) address

-Specific dates (birth dates, death dates, examination dates, etc.)

-Contact information such as phone number or email address

-Location data

-ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order)

Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants.

Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long.

Please remove or anonymize all personal information (<specific identifying information in file to be removed>), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file.

4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

Reviewer #1: Epidemiological analysis reveals coral species affected by Stony Coral Tissue Loss Disease present a similar epizootic progression despite differences in susceptibility and population impact. by E. Omar Guzmán-Urieta1, 2*, Eric Jordán-Dahlgren3, Lorenzo Alvarez-Filip2 PONE-D-25-35026

Overview: Authors attempt to describe temporal aspects of SCTLD in Mexican reefs. I like what authors are trying to do, but their approach seems overly convoluted and difficult to understand. Unless we have more details on how they did their surveys, estimates of underlying populations at risk, it becomes difficult to sort out potential confounding factors (like survey effort or number of animals available to observe) that could sway the results. The presentation of material is also garbled and does not make sense at least to this reviewer. There is definitely something interesting here but authors need to clarify, condense, and simplify to get their point across. I sense that the main points of the paper could be captured with Figures 2 and 4 with everything else deleted to simplify. Bottom line, you could get a good idea of interspecies susceptibility by plotting epidemic curves and calculating case fatality rate (the higher, the more susceptible the species). This would be cleaner and simpler to present to get your point across without a lot of convolution.

Line 79: Punctual prevalence is redundant. Just state prevalence which is percent of diseased animals at a point in time. Incidence is change in prevalence over time.

Lines 92-97: Difficult here to understand what you are saying. I suspect something along the following?: "Illustrative of this concept is the study by Dahlgren et al. [24] showing changes in prevalence of SCTLD by species over time."

Lines 104-105. Delete. It is obvious that a single sampling will not capture changes over time.

LInes 158-163: More detail on survey methodology would help here to assess validity of finding. A key aspect of temporal disease studies is implementing consistent effort spatially. Were permanent transects used and surveyed over time? Did you mark colonies? As written, it is difficult to say whether, for example, increased prevalence for a particular species was due to surveys with more of that species at a particular time point. It seems all this could be greatly simplified to present disease incidence by species to give a reader a sense of how disease varies between hosts coupled with case fatality rate for those colonies for which you have temporal observations. The latter would also address just how accurate Table 1 is for your region.

Lines 164-166: Were these colonies marked and followed over time? How were individual colonies recognized over time?

Lines 190-196: I don't understand. Fig. S1 is implying each colony has 2 observations but you are talking about 1 monitoring date.

Fiure S1. This caption and figure makes no sense to this reviewer. I just don't understand how you can calculate rate of tissue loss over time from a single observation.

Lines 197-205: This reads like Greek to me.

Figure S2: Seems all this could be simplified to something like acute, subacute and chronic tissue loss. I have a hard time distinguishing all the other categories you are stating

Lines 169-209: Seems all this could be considerably simplified and condensed to the following: Calculation of tissue loss rate over 2 or 3 time points using linear models. Attempting to calculate tissue loss rate from single observations is stretching it and would suggest delete those two parts (lines 197-205).

Line 215: Do you mean: "These curves were computed by species and by species grouped to expected susceptibility (high,intermediate and low) (Cite)"?

Lines 216-220: What exactly are you trying to say here?

Lines 227-229: condense: "Epi curves were generated from weekly tallies."

Lines 236-239: What is this association you are trying to make? How exactly did you compare density distribution of disease vs mortality? And why only compare density of disease between sites but nor mortality?

Line 262: Earlier, you said epidemic curves were generated from weekly tallies. Now you say daily. Which is it?

Lines 287-289: Delete. This does not add anything meaningful to previous sentence and overly complicates things and seems arbitrary (what is magical about 5%? why not 10%? 20%?).

Lines 291-298: Just how meaningful is this? Can you delete to simplify and get to the point?

Lines 299-326: Ditto.

Figure 2. Here it would be helpful to have actual N of colonies represented for each plot. I suspect for some plots (e.g. meandrina, dichocoenia,Porites), those are simply reflective of fact that those species are likely less numerous on reefs. Indeed, consider plotting curves only for species for which you have a minimal N (e.g. 20+) to make the data meaningful. Indeed, based on your data, I suspect susceptibility Table 1 is simply a function of how commonly those species are encountered and this could be a confounding factor (more disease simply because it is easier to detect and may not have anything to do with species susceptibility). Any way to correct for that? Indeed, a plot between relative numbers of each species at a site and the slope of population at risk (blue line) in your plot figure 2 might be informative. The closer the slope is to 0 or 1 suggests rare species which would be only those corals in intermediate slope values should really be considered when assessing epidemic curves.

Figure 2 caption: "This is the point of time when the number of newly diseased individuals was maximum and then began to decline." Delete...redundant. Flashing line...do you mean solid black line?

Figure 3. Consider deleting. This really does not add anything meaningful to your story and is redundant to Figure 2.

Lines 404-407:"Furthermore, the species A. agaricites, A. tenuifolia, I. sinuous, S. intersepta, and P. porites exhibited low survival probabilities for their diseased populations (below 11 %), despite their at-risk populations showing moderate to high survival probabilities (S4 Fig)

Figure 5 and 6: Delete. Does not really add anything meaningful to the story.

Keep figure S2 and S3 and delete the rest. Those do not add anything meaningful to story.

Lines 418-421: Delete. Not sure what this adds.What pairwise comparisons were different?

Lines 422-429: Condense to: "there were no statistically significant differences in

429 survival probabilities among the diseased populations."

Lines 432-438: What is your point here? This paragraph makes no sense.

Lines 439-444: Seems from FIgure 2 that prevalence peaked out at 1 for all species suggesting they are all equally susceptible no?

Lines 446-492: This is all very convoluted, and without an appreciation of underlying N for each species surveyed, it is difficult to sort out here whether these data are indicative of species susceptibility or simply an artefact that there is less disease evidence in species that are less visible or common.

Line 457/Fig 6: Why are you splitting them on PC1? Why not PC2? Also, not understanding the rationale for the cutoffs for the 4 groups on PC1? Seems I could make my on grouping 1-4 based on PC quadrats. For example for outbreak length (PSTR, SSID, PCLI, MCAV), P survival (PAST, AAGA< OFAV, ATEN, OANN), etc. This all seems arbitrary to me.

Lines 510-512: It is already known that there is difference in species susceptibility to SCTLD.

Reviewer #2: Please see attached file.

Reviewer #3: I recommend that this manuscript needs significant revisions. This study addresses an important topic by applying epidemiological tools to coral disease; however, there are concerns regarding the limitations of the models and the results not supporting the claims in the discussion that need to be addressed before publication. Please see below for more comments and line by line suggestions.

PONE-D-25-35026 Comments to Authors

General comments:

The conclusion that mortality appears to contribute to secondary transmission events should be more of a hypothesis as it is speculative. I suggest changing the terminology throughout the manuscript to soften the language as this is a hypothesis.

The figure descriptions are very long and also have some discussion points in them. I suggest removing the discussion points from the legends and including them in the manuscript if necessary (e.g., lines 104-105 are discussion points). Some of the figures are complicated, so potential reworking may be needed.

Point prevalence is the more commonly used term compared to punctual prevalence and should be changed throughout the manuscript.

The limitations of the models need to be highlighted and discussed throughout the manuscript.

General methods:

Though there was no difference in spatial distribution between sites, there needs to be evidence presented (I.e. supplementary statistics) that there are no incidence differences between sites. Since the authors are referring to temporal dynamics and not spatial distribution for these data, analyses need to be run to determine if the sites can be pooled.

Why were only 422 corals used to estimate tissue loss per day when 990 had signs of SCTLD? It says further analyses were used for these 990, but more than half were not put into any of the models. Was a model applied to the other >500 corals? If so, which one was it applied to? That needs to be stated directly. If not used in this study, then those should be removed from the methods, table 1, discussion, etc.

Models 3 and 4 – These need to be presented with more caution. Model 3 relies on observations of corals of the same species and size while Model 4 relies on a perceived timeline, and it needs to be addressed that these are less reliable methods to infer incidence.

For the PCA – how were the variables scaled?

Species with a low sample size need to be addressed as a limitation of these models. For example, M. jacksoni is presented within figure 2, but only had a sample size of 2.

Figure 2 is overly complex, making it difficult to interpret. Consider simplifying or splitting into multiple panels.

General discussion:

The structure of the discussion needs to be re-worked to have a better flow. Suggestion: summary of main findings, comparisons with previous work, interpretations of key patterns, limitations, implications for future use.

The language has to be softened within this section. For example, “point prevalence may not always be a reliable indicator of susceptibility, especially when measured at a single time point.”

The PCA provides an exploratory framework for susceptibility, and it complements existing classifications, but tone down the language regarding the novel classification.

In general, the language regarding the “secondary waves caused by sloughed off tissue” needs to be softened as it is a hypothesis and cannot be proven with modeling.

It is unusual to have phrased questions throughout – consider revising for easier reading.

Lines 636-650 – it is unclear why there is significant detail regarding opportunistic infections and the coral’s response. I suggest cutting down on these sections as they have been described in other studies and do not necessarily discuss the results of this study. Or potentially adjust the flow of the discussion so that the interpretation of susceptibility differing is clearer.

I highly suggest adding a limitations section to the discussion where the drawbacks of the models are discussed. For example, limitations include variation in sample size, inferred incidence for Models 3 and 4, pooling sites, non-independence of colonies, etc.

Consider adding a final paragraph discussing the implications of the modeling and how they can be used in the future. Suggestions include for future outbreaks, provide targeted interventions, aid mangagement decisions, etc.

Finally, consider adding Aeby et al 2025 “Progressive chronic tissue loss disease in Siderastrea siderea on Florida’s coral reef” as a potential explanation for the Sids species susceptibility differences.

Line by line suggestions:

Line 38 – mortality may contribute to secondary transmission

Line 41 – say what you are comparing the higher level of susceptibility to – i.e., previous studies

Line 51 – sensible doesn’t fit here. Sensitive? Susceptible?

Line 58 – stony coral tissue loss disease is lowercase

Lines 73 – 76 – the wording is confusing to read. Revise the “will also have likely compromised.” Potentially break into two sentences as well for clarity

Line 79 – Change “punctual prevalence” to “point prevalence” throughout the manuscript as it is more the more commonly used term.

Line 84 – change “lesions apparition” to “lesion appearance” if that maintains the meaning of the sentence

Line 88 - “giving an incomplete picture” is awkward phrasing for the sentence. Consider revising

Line 100 figure 1 description – there are no white arrows within the figure, so assuming you are referring to black arrows. Remove discussion/result points from the figure descriptions.

Line 111 – Revise sentence to avoid starting with “which.” Potentially combine with previous sentence.

Line 137 – Consider “epi-curves, Kaplan-Meier risk curves, and survival curves” if it maintains meaning.

Line 182 – Repeated measures within the same individuals may violate independence assumptions of some models and should be stated that it should be interpreted with caution.

Line 219 – change to epizootic

Lines 233-236 – the language here needs to be softened as correlation does not mean causation, and this is a hypothesis

Line 270-273 – revise sentence for readability

Line 289 – change “umbral” to “threshold”

Line 292 – change to “on the other hand”

Line 339 figure 2 description – “flashing is unclear” changed to dashed or change the figure so that the dotted and dashed black lines are easier to differentiate

Lines 357 – 371 – the sample size of the corals needs to be clearly addressed when comparing between species.

Line 381-382 – revise for clarity

Lines 392-393 – revise to “this patten is consistent with the hypothesis” as it does not prove it. It is not possible to confirm that sloughing off tissue is causing a secondary wave with these models alone.

Line 409 figure 5 description – revise for clarity about B and C

Line 429 – change to log rank

Line 471 – revise for clarity

Figure 6 and description – the four “levels” of susceptibility are not based on formal clustering, which makes this classification subjective. Reframe to be exploratory instead of discrete groups. Clarify how the variables were standardized before the PCA. The legend is dense and hard to follow, so the text needs to be simplified. The results are interesting, but the interpretation should be more cautious and should be presented as exploratory rather than definitive evidence of a new susceptibility classification.

Lines 510-512 – revise for clarity

Line 512 – species' if it maintains clarity

Line 527 – point prevalence may not be a reliable measure

Line 557 – outbreak duration may not be a reliable measure

Lines 574-575 – revise for clarity

Lines 581 – 582 – soften this language as this is not direct evidence from the field and these observations need experimental manipulations instead of modeling to prove causation and not just correlation

Line 608 – revise so the sentence does not start with which

Lines 610-619 – add Palacaio-Castro “elevated temperature decreases stony coral tissue loss disease transmission, with little effect of nutrients” to discussion

Line 652 - “is not against” is unclear to read

Line 671 – misused may not be the appropriate term here

Line 672-674 – soften the language here as the models could aid in elucidating the etiology of SCTLD

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Thierry M. Work

Reviewer #2: Yes:  Aine Hawthorn

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PLOSOne SCTLD epi.docx

pone.0339054.s012.docx (15.2KB, docx)
PLoS One. 2026 Jan 2;21(1):e0339054. doi: 10.1371/journal.pone.0339054.r002

Author response to Decision Letter 1


5 Nov 2025

Response to Academic Editor:

Academic Editor recommendations:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

We have reviewed the PLOS ONE style requirements and ensured that they are followed in the manuscript, including file naming.

2. Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

I have included the founding statement at the end of the cover letter, including the requested information.

3. We note that there is identifying data in the Supporting Information file <S2 Table>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws.

I appreciate the comment; however, it appears to be a misunderstanding. Table S2 contains a bibliographic summary of scientific publications related to coral disease research. It includes only the information necessary for citation purposes, such as authors' names, publication title, year, journal name, and similar details. This work does not involve human subjects.

4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Thank you very much. We have considered including additional citations where appropriate.

Response to Reviewers:

Reviewer #1

Overview: Authors attempt to describe temporal aspects of SCTLD in Mexican reefs. I like what authors are trying to do, but their approach seems overly convoluted and difficult to understand. Unless we have more details on how they did their surveys, estimates of underlying populations at risk, it becomes difficult to sort out potential confounding factors (like survey effort or number of animals available to observe) that could sway the results. The presentation of material is also garbled and does not make sense at least to this reviewer. There is definitely something interesting here but authors need to clarify, condense, and simplify to get their point across. I sense that the main points of the paper could be captured with Figures 2 and 4 with everything else deleted to simplify. Bottom line, you could get a good idea of interspecies susceptibility by plotting epidemic curves and calculating case fatality rate (the higher, the more susceptible the species). This would be cleaner and simpler to present to get your point across without a lot of convolution.

We sincerely thank the reviewer for their thoughtful and constructive comments. In response, we have carefully revised and substantially edited the Methods section to clarify the survey design, sampling effort, and estimation of populations at risk. We also reviewed the entire manuscript to improve clarity and flow, aiming to make our approach more accessible. Please refer to your and the other reviewer's specific comments for details on how we have amended the manuscript.

We appreciate the suggestion to focus on Figures 2 and 4, which indeed highlight key aspects of susceptibility at population and community levels. However, we consider the additional analyses essential to support a more robust and biologically grounded interpretation. In coral disease studies, susceptibility is often inferred from prevalence alone, which overlooks the temporal progression of outbreaks, survival dynamics, and epidemic risk. Our approach, based on epidemic curves and Kaplan-Meier survival analysis, was designed to address these limitations and evaluate susceptibility in a temporally explicit framework.

Although this may increase the apparent complexity of the work, we consider it necessary to reflect the biological and epidemiological realities of SCTLD. While we acknowledge the communicative value of case fatality rate, we believe our framework already offers a more comprehensive representation of disease severity and susceptibility without calculating CFR separately.

Line 79: Punctual prevalence is redundant. Just state prevalence which is percent of diseased animals at a point in time. Incidence is change in prevalence over time.

Thank you. We agree and have changed to ‘prevalence’ as suggested.

Lines 92-97: Difficult here to understand what you are saying. I suspect something along the following?: "Illustrative of this concept is the study by Dahlgren et al. [24] showing changes in prevalence of SCTLD by species over time."

Thank you. We have reworded this section (lines 90 to 96) to enhance clarity and better convey the intended argument.

Lines 104-105. Delete. It is obvious that a single sampling will not capture changes over time.

Deleted as suggested.

LInes 158-163: More detail on survey methodology would help here to assess validity of finding. A key aspect of temporal disease studies is implementing consistent effort spatially. Were permanent transects used and surveyed over time? Did you mark colonies? As written, it is difficult to say whether, for example, increased prevalence for a particular species was due to surveys with more of that species at a particular time point. It seems all this could be greatly simplified to present disease incidence by species to give a reader a sense of how disease varies between hosts coupled with case fatality rate for those colonies for which you have temporal observations. The latter would also address just how accurate Table 1 is for your region.

Lines 164-166: Were these colonies marked and followed over time? How were individual colonies recognized over time?

The two previous comments will be answered below.

We thank the reviewer for these valuable observations. We have expanded the methods section to explain these key aspects of data collection. This more detailed description is between lines 155 – 170, as follows:

“At Bocana, four sampling points were established: B1 (453 m²), B2 (19.5 m²), B3 (140 m2), and B4 (60 m²). At Picudas, three points were defined: P1 (435 m²), P2 (12 m²) and P3 (9 m²). These polygons were delimited by reef topography and visibility constraints, but remained fixed throughout the study. Despite differences in size, consistent effort was applied within each polygon to document all visible coral colonies across species during each visit through photographic surveys.

Initially, monitoring was focused on spatial disease patterns in Pseudodiploria strigosa, as part of a previous study on SCTLD dynamics [26]. However, during those surveys, photographic records were systematically taken of all visible coral colonies within the same sampling areas, regardless of species. Each colony was photographed individually during every monitoring event, with multiple angles captured depending on its size and structural complexity. These images allowed us to track colonies over time and retrospectively assess their health status (healthy, diseased, or dead), visually estimate the percentage of dead tissue caused by SCTLD or previous mortality, and classify lesion progression type (acute, subacute, or chronic, sensu Work & Aeby [46]). Additionally, the maximum diameter of each colony at the onset of the study was measured using ImageJ (1.52a), based on scale markers included in the photographs.”

Lines 190-196: I don't understand. Fig. S1 is implying each colony has 2 observations but you are talking about 1 monitoring date.

Fiure S1. This caption and figure makes no sense to this reviewer. I just don't understand how you can calculate rate of tissue loss over time from a single observation.

Lines 197-205: This reads like Greek to me.

The three previous comments will be answered below.

Thank you for your comments. This part of the method aims to estimate the onset of lesion signs and the timing of total tissue loss in colonies with only one recorded observation. To improve clarity, we have revised the manuscript text and restructured it as follows (now in lines 209 – 238):

“For colonies with only one recorded observation of tissue loss, we acknowledge that direct estimation of lesion progression is not possible. To avoid excluding these cases, we implemented two approaches based on biologically informed assumptions and empirical reference data. These methods aim to reconstruct plausible trajectories while accounting for uncertainty, as detailed in points III and IV.

III. The third approach was implemented for diseased colonies with only one recorded instance of tissue loss. These cases occurred either because the colonies were too small to relocate or because they died and were likely rapidly overgrown by algae, resulting in their capture as diseased during only one survey (n = 130). To address this limitation, we assumed that these individuals followed a similar trajectory to others of the same species, size category (small: <33 cm; medium: >33 to 66 cm; large: >66 to <100 cm; and extra-large: >100 cm), and lesion progression type. Based on this assumption, we first calculated individual tissue loss trajectories from colonies with sufficient temporal data, grouped by species, size category, and lesion progression type. From these trajectories, we derived an average daily tissue loss rate, which was then used to interpolate the percentage of tissue loss for colonies with only one recorded observation. This allowed us to estimate the full progression trajectory, including onset and extent of tissue loss, for single-observation cases. This procedure is illustrated in S1 Fig. A 95% confidence interval for each extrapolated trajectory was computed using the bootstrap percentile method and is provided for reference (S4 Table).

IV. For diseased colonies with only one tissue mortality record that could not be matched to any of the above categories of species, size, and lesion progression (n = 88), we estimated their individual tissue loss trajectories based on the colonization stage of the exposed skeleton. These stages (recent mortality, algal/microbial film, turf algae, and macroalgae) follow a consistent post-mortality succession (S2 Fig). Each stage was associated with an average transition time, calculated from a reference subsample of 157 colonies (S5 Table). Using this information, we inferred when each skeletal region was covered by living tissue. Colonies displaying multiple colonization stages provided several time points along the lesion progression. Depending on the number of inferred points, we then applied either a GAMM or a linear interpolation method (as in cases I and II, respectively) to reconstruct the full trajectory of tissue loss, from lesion onset to complete mortality.”

And the S1 Figure legend accordingly (lines 944 – 951):

“S1 Fig. Estimation of lesion progression for colonies with only one recorded tissue loss value. Example for P. strigosa (medium size, acute lesion progression, n = 12): A) Daily tissue loss trajectories from colonies with multiple observations were grouped by species, size category, and lesion progression type. Each colored line is an individual trajectory. B) Time was normalized around the 50% tissue loss point to align trajectories and estimate average trajectory. C) The average trajectory (blue line) and its 95% confidence interval (blue ribbon) were computed via bootstrap percentile method. D) Red dots show single-record colonies; their lesion progression was extrapolated using the reference trajectory, assuming similar dynamics.”

Figure S2: Seems all this could be simplified to something like acute, subacute and chronic tissue loss. I have a hard time distinguishing all the other categories you are stating

Thank you very much for your comment. In this case, the categories correspond to colonization stages. Although there is a close relationship between these colonization stages and the rate of tissue loss, we want to relate time to the cover sequence. Therefore, we have retained the category structure explained in the legend for Figure S2 but revised both the legend and the figure itself to improve clarity and visual interpretation.

Lines 169-209: Seems all this could be considerably simplified and condensed to the following: Calculation of tissue loss rate over 2 or 3 time points using linear models. Attempting to calculate tissue loss rate from single observations is stretching it and would suggest delete those two parts (lines 197-205).

Thank you for your comment. We understand the concern regarding inference from single observations. However, our goal was not to calculate tissue loss rates directly from isolated data points, but rather to reconstruct plausible progression trajectories using systematic, biologically informed methods. For colonies with only one recorded observation, we relied on patterns derived from individuals of the same species, size category, and lesion type (approach III), or from the colonization stage of the exposed skeleton (approach IV), both of which are grounded in empirical data. These methods allowed us to estimate onset and extent of tissue loss in a reproducible and transparent way, while acknowledging uncertainty through confidence intervals (S4 & S5 tables). We believe this approach adds value by recovering otherwise lost information and enabling inclusion of these cases in broader epidemiological analyses. Nonetheless, we have revised the text to improve clarity and emphasize the assumptions and limitations involved. The clarified text is now found between lines 180 and 242, cited above. On the other hand, we have added a note of methodological considerations and limitations at the end of the discussion where we include this point (lines 649 – 656):

“For colonies with only one recorded observation of tissue loss, inference-based approaches (III and IV, see methods) were applied transparently, incorporating ecological indicators and uncertainty. Among these single-record cases, the distribution across susceptibility groups was approximately balanced (57% high, 44.5% intermediate, 62% low; relative to diseased colonies in each group), suggesting no systematic bias toward any group. A more influential factor was colony size: 61% of these cases corresponded to small colonies. We consider that this approach adds value by recovering information that would otherwise be excluded and by enabling the inclusion of these cases in broader epidemiological analyses”

Line 215: Do you mean: "These curves were computed by species and by species grouped to expected susceptibility (high,intermediate and low) (Cite)"?

Exactly, we have revisited this section to improve clarity and ensure the grouping logic is clearly conveyed. Lines 247-253.

Lines 216-220: What exactly are you trying to say here?

We have adjusted the text, now on lines 249-253 for clarity:

“This analysis evaluates whether species grouped by expected susceptibility-based groups exhibit consistent differences not only in period prevalence and cumulative mortality, but also in other epidemiological indicators throughout the course of the epizootic. The list of species by group is provided in Table 1.”

Lines 227-229: condense: "Epi curves were generated from weekly tallies."

We appreciate the suggestion and have condensed, now in lines 265-266.

Lines 236-239: What is this association you are trying to make? How exactly did you compare density distribution of disease vs mortality? And why only compare density of disease between sites but nor mortality?

Thank you for your observations. We have clarified the text to specify that the association being explored is whether mortality could help explain the observed incidence patterns. Additionally, we clarified that both incidence and mortality distributions were co

Attachment

Submitted filename: Response to Reviewers.docx

pone.0339054.s014.docx (57.4KB, docx)

Decision Letter 1

Parviz Tavakoli-Kolour

1 Dec 2025

Epidemiological analysis reveals coral species affected by Stony Coral Tissue Loss Disease present a similar epizootic progression despite differences in susceptibility and population impact.

PONE-D-25-35026R1

Dear Dr. Guzman,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Parviz Tavakoli-Kolour

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

**********

Reviewer #2: (No Response)

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: Yes:  Aine Hawthorn

**********

Acceptance letter

Parviz Tavakoli-Kolour

PONE-D-25-35026R1

PLOS One

Dear Dr. Guzmán-Urieta ,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Parviz Tavakoli-Kolour

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Estimation of lesion progression for colonies with only one recorded tissue loss value.

    Example for P. strigosa (medium size, acute lesion progression, n = 12): A) Daily tissue loss trajectories from colonies with multiple observations were grouped by species, size category, and lesion progression type. Each colored line is an individual trajectory. B) Time was normalized around the 50% tissue loss point to align trajectories and estimate average trajectory. C) The average trajectory (blue line) and its 95% confidence interval (blue ribbon) were computed via bootstrap percentile method. D) Red dots show single-record colonies; their lesion progression was extrapolated using the reference trajectory, assuming similar dynamics.

    (PDF)

    pone.0339054.s001.pdf (18.1MB, pdf)
    S2 Fig. Identification of the stages of colonization of the denuded coral skeleton by SCTLD.

    Process illustrated with two colonies of P. strigosa. Dual view per colony: natural appearance (top) and colonization stage overlays (bottom). Legend at the lower right corner. Colonization stages are arranged outward from the living tissue and delineated by distinct line patterns in the following order: Recently dead (almost pure white coloration), Film 1 (incipient microbial film), Film 2 (well-established microbial biofilm; denser algal films with more saturated hues), Film 3 (incipient algal mat; filamentous algae beginning to establish, with possible sediment entrapment), Turf algae (denser mats of juvenile macroalgae or filamentous algae), and Macroalgae (advanced macroalgal growth, often identifiable to genus level).

    (PDF)

    pone.0339054.s002.pdf (20.3MB, pdf)
    S3 Fig. Probability of becoming diseased by species.

    Colored bands represent the 95% Confidence Interval. Colors indicate the expected susceptibility groups: red for high susceptibility, yellow for medium susceptibility, and blue for low susceptibility. A notable decrease in risk is observed as one moves to lower levels of expected susceptibility. However, some species, such as P. clivosa, S. siderea, and S. intersepta, display values that deviate from their expected susceptibility groups. Overall, the medium susceptibility group exhibited greater heterogeneity.

    (PDF)

    pone.0339054.s003.pdf (423.6KB, pdf)
    S4 Fig. Kaplan-Meier survival probability curves for the population (blue lines) and diseased individuals (red lines) by species.

    Bands represent the 95% Confidence Interval. For clarity, graphs display data up to day 600 from the outbreak onset. Decreases in survival probabilities occurred beyond day 600 are depicted as vertically dashed lines. These lines do not indicate sudden drops at that point but summarize posterior mortality up to 2.8 years.

    (PDF)

    pone.0339054.s004.pdf (50.4KB, pdf)
    S5 Fig. Sub-sampling of prevalence of SCTLD by species at 100, 200, 300, 400, 500 and 600 days from the onset of epizootic.

    Colors show the expected susceptibility group: High (red), Intermediate (yellow), and Low (blue). Panels show that prevalence comparisons between species differed at each time point. Furthermore, the prevalence levels of species mostly failed to match the expected susceptibility patterns across the sub-sampled periods.

    (PDF)

    pone.0339054.s005.pdf (678.3KB, pdf)
    S1 Table. Frequency of use of parameters to classify species susceptibility to SCTLD.

    (PDF)

    pone.0339054.s006.pdf (140.6KB, pdf)
    S2 Table. Web of Science studies about coral epizootics from 1995 to 2025.

    (XLSX)

    pone.0339054.s007.xlsx (88.7KB, xlsx)
    S3 Table. GAMM’s models validation.

    The table shows the results of the normality, homoscedasticity, and autocorrelation tests on the residuals, as well as the model fit (R² values).

    (XLSX)

    pone.0339054.s008.xlsx (28KB, xlsx)
    S4 Table. Onset and complete mortality days calculation through average tissue loss rates.

    (XLSX)

    pone.0339054.s009.xlsx (27.7KB, xlsx)
    S5 Table. Mean time of change from apparently healthy tissue adjacent to any lesion to each stage of colonization.

    Status codes: Recently dead, denotes recently denuded skeleton; Film 1 is a scarce microbial/algal film; Film 2 is a well-stablished biofilm; Film 3 incipient turf algae mats; Turf Algae, denser turf algae mats; Macro Algae, macroalgal patches identifiable to genus level. (n) is the number of colonies analyzed to time calculations. CI = Confidence Interval of the 95%.

    (PDF)

    pone.0339054.s010.pdf (94.3KB, pdf)
    S1 Dataset. Complete dataset. Containing dates and times of onset and mortality or recovery, size, type of lesion progression, and expected susceptibility of each colony.

    (XLSX)

    pone.0339054.s011.xlsx (81.3KB, xlsx)
    Attachment

    Submitted filename: PLOSOne SCTLD epi.docx

    pone.0339054.s012.docx (15.2KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0339054.s014.docx (57.4KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES